# EDGAR Filing Document

**Accession Number:** 0000098362
**File Stem:** 0000098362-25-000114
**Filing Date:** 2025-7
**Character Count:** 176419
**Document Hash:** 137ee46f54d90114e4a46c6b263b3d87
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000098362-25-000114.hdr.sgml**: 20250730

**ACCESSION NUMBER**: 0000098362-25-000114

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 98

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250730

**DATE AS OF CHANGE**: 20250730

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TIMKEN CO
- **CENTRAL INDEX KEY:** 0000098362
- **STANDARD INDUSTRIAL CLASSIFICATION:** BALL & ROLLER BEARINGS [3562]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 340577130
- **STATE OF INCORPORATION:** OH
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-01169
- **FILM NUMBER:** 251166750

**BUSINESS ADDRESS:**
- **STREET 1:** 4500 MT. PLEASANT ST. NW
- **CITY:** NORTH CANTON
- **STATE:** OH
- **ZIP:** 44720-5450
- **BUSINESS PHONE:** (234) 262-3000

**MAIL ADDRESS:**
- **STREET 1:** 4500 MT. PLEASANT ST. NW
- **CITY:** NORTH CANTON
- **STATE:** OH
- **ZIP:** 44720-5450

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TIMKEN ROLLER BEARING CO
- **DATE OF NAME CHANGE:** 19710304

?xml version='1.0' encoding='ASCII'? tkr-20250630

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

![timkenlogoa50.jpg](tkr-20250630_g1.jpg)

**FORM 10-Q** 

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended June 30, 2025** 

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**

**Commission file number: 1-1169** 

**THE TIMKEN COMPANY**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Ohio** | **Ohio** | **34-0577130** |
| **(State or other jurisdiction of<br>incorporation or organization)** | **(State or other jurisdiction of<br>incorporation or organization)** | **(I.R.S. Employer<br>Identification No.)** |
| **4500 Mount Pleasant Street NW** | **4500 Mount Pleasant Street NW** | |
| **North Canton** | **Ohio** | **44720-5450** |
| **(Address of principal executive offices)** | **(Address of principal executive offices)** | **(Zip Code)** |

---

**234.262.3000** 

**(Registrant's telephone number, including area code)**

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol** | **Name of each exchange on which registered** |
| Common Shares, without par value | TKR | The New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☐ |
| Non-accelerated filer | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;No ☒

Indicate the number of shares outstanding of each of the issuer's classes of common shares, as of the latest practicable date.

 Class Outstanding at June 30, 2025 <br> Common Shares, without par value 69,643,004 shares

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

THE TIMKEN COMPANY

INDEX TO FORM 10-Q REPORT

---

| | | | |
|:---|:---|:---|:---|
| | | | <u>PAGE</u> |
| I. | <u>[PART I.](#i38983723d3ff4cd89864b8cd2aa3c059_10)</u> |  |  |
|  | Item 1. | <u>[Financial Statements](#i38983723d3ff4cd89864b8cd2aa3c059_13)</u> | <u>[1](#i38983723d3ff4cd89864b8cd2aa3c059_13)</u> |
|  | Item 2. | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i38983723d3ff4cd89864b8cd2aa3c059_103)</u> | <u>[29](#i38983723d3ff4cd89864b8cd2aa3c059_103)</u> |
|  | Item 3. | <u>[Quantitative and Qualitative Disclosures about Market Risk](#i38983723d3ff4cd89864b8cd2aa3c059_217)</u> | <u>[49](#i38983723d3ff4cd89864b8cd2aa3c059_217)</u> |
|  | Item 4. | <u>[Controls and Procedures](#i38983723d3ff4cd89864b8cd2aa3c059_220)</u> | <u>[49](#i38983723d3ff4cd89864b8cd2aa3c059_220)</u> |
| II. | <u>[PART II.](#i38983723d3ff4cd89864b8cd2aa3c059_223)</u> |  |  |
|  | Item 1. | <u>[Legal Proceedings](#i38983723d3ff4cd89864b8cd2aa3c059_226)</u> | <u>[50](#i38983723d3ff4cd89864b8cd2aa3c059_226)</u> |
|  | Item1A. | <u>[Risk Factors](#i38983723d3ff4cd89864b8cd2aa3c059_229)</u> | <u>[50](#i38983723d3ff4cd89864b8cd2aa3c059_229)</u> |
|  | Item 2. | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i38983723d3ff4cd89864b8cd2aa3c059_232)</u> | <u>[50](#i38983723d3ff4cd89864b8cd2aa3c059_232)</u> |
|  | Item 5. | <u>[Other Information](#i38983723d3ff4cd89864b8cd2aa3c059_235)</u> | <u>[51](#i38983723d3ff4cd89864b8cd2aa3c059_235)</u> |
|  | Item 6. | <u>[Exhibits](#i38983723d3ff4cd89864b8cd2aa3c059_238)</u> | <u>[51](#i38983723d3ff4cd89864b8cd2aa3c059_238)</u> |

---

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

**PART I. FINANCIAL INFORMATION**

**ITEM 1. FINANCIAL STATEMENTS**

**THE TIMKEN COMPANY AND SUBSIDIARIES**

**Consolidated Statements of Income**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | 2024 | **2025** | 2024 |
| (Dollars in millions, except per share data) |  |  |  |  |
| Net sales | $**1173.4** | $1182.3 | $**2313.7** | $2372.6 |
| Cost of products sold | **813.1** | 808.7 | **1594.7** | 1601.4 |
| Selling, general and administrative expenses | **189.7** | 184.1 | **374.5** | 374.8 |
| Amortization of intangible assets | **19.9** | 19.0 | **38.9** | 39.0 |
| Impairment and restructuring charges | **2.9** | 3.3 | **13.8** | 5.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Operating Income** | **147.8** | 167.2 | **291.8** | 351.8 |
| Interest expense | **(29.8)** | (34.6) | **(56.3)** | (66.8) |
| Interest income | **3.0** | 5.1 | **5.3** | 7.9 |
| Non-service pension and other postretirement expense | **(1.2)** | (1.0) | **(2.4)** | (2.0) |
| Other (expense) income, net | **(3.4)** | 1.2 | **(3.7)** | 0.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Income Before Income Taxes** | **116.4** | 137.9 | **234.7** | 291.2 |
| Provision for income taxes | **30.7** | 35.9 | **57.6** | 78.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net Income** | **85.7** | 102.0 | **177.1** | 212.6 |
| Less: Net income attributable to noncontrolling interest | **7.2** | 5.8 | **20.3** | 12.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net Income Attributable to The Timken Company** | $**78.5** | $96.2 | $**156.8** | $199.7 |
| **Net Income per Common Share Attributable to The Timken <br>&nbsp;&nbsp;&nbsp;&nbsp;Company Common Shareholders** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Basic earnings per share** | $**1.13** | $1.37 | $**2.24** | $2.84 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Diluted earnings per share** | $**1.12** | $1.36 | $**2.23** | $2.82 |

---

See accompanying Notes to the Consolidated Financial Statements.

**Consolidated Statements of Comprehensive Income**

**(Unaudited)** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | 2024 | **2025** | 2024 |
| (Dollars in millions) |  |  |  |  |
| Net Income | $**85.7** | $102.0 | $**177.1** | $212.6 |
| Other comprehensive income (loss), net of tax: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation adjustments | **143.6** | (29.3) | **210.7** | (80.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pension and postretirement liability adjustments | **(1.7)** | (1.5) | **(3.3)** | (3.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of derivative financial instruments | **(3.6)** | (0.8) | **(5.7)** | 0.3 |
| Other comprehensive income (loss), net of tax | **138.3** | (31.6) | **201.7** | (82.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Comprehensive income, net of tax** | **224.0** | 70.4 | **378.8** | 129.9 |
| Less: comprehensive income attributable to noncontrolling interest | **6.8** | 5.7 | **20.5** | 12.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Comprehensive income attributable to The Timken Company** | $**217.2** | $64.7 | $**358.3** | $117.5 |

---

See accompanying Notes to the Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

**Consolidated Balance Sheets**

---

| | | |
|:---|:---|:---|
| | **(Unaudited)** | |
| (Dollars in millions) | **June 30,<br>2025** | December 31,<br>2024 |
| **ASSETS** |  |  |
| **Current Assets** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $**419.3** | $373.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | **1.5** | 0.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | **785.6** | 664.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unbilled receivables | **153.2** | 140.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories, net | **1222.1** | 1195.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred charges and prepaid expenses | **46.0** | 39.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current assets | **92.0** | 102.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Current Assets** | **2719.7** | 2516.9 |
| **Property, Plant and Equipment, net** | **1351.3** | 1306.9 |
| **Other Assets** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goodwill | **1488.0** | 1383.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other intangible assets, net | **1043.4** | 1006.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease assets | **132.5** | 130.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | **48.5** | 41.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other non-current assets | **30.5** | 25.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Other Assets** | **2742.9** | 2587.2 |
| **Total Assets** | $**6813.9** | $6411.0 |
| **LIABILITIES AND EQUITY** |  |  |
| **Current Liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable, trade | $**347.0** | $321.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Short-term debt, including current portion of long-term debt | **58.7** | 13.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Salaries, wages and benefits | **135.2** | 142.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | **13.8** | 24.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | **315.0** | 319.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Current Liabilities** | **869.7** | 820.5 |
| **Non-Current Liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term debt | **2139.6** | 2049.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued pension benefits | **145.3** | 157.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued postretirement benefits | **29.8** | 29.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term operating lease liabilities | **85.7** | 84.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | **168.8** | 175.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other non-current liabilities | **102.2** | 110.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Non-Current Liabilities** | **2671.4** | 2606.4 |
| **Shareholders' Equity** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I and II Serial Preferred Stock, without par value: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Authorized – 10,000,000 shares each class, none issued | **—** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common shares, without par value: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Authorized – 200,000,000 shares |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issued (including shares in treasury) (2025 – 79,576,690 shares; <br>&nbsp;&nbsp;&nbsp;&nbsp; 2024 – 79,173,667 shares) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stated capital | **40.7** | 40.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other paid-in capital | **1284.2** | 1269.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | **2596.1** | 2488.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | **(100.2)** | (301.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasury shares at cost (2025 – 9,933,686 shares; 2024 – 9,174,863 shares) | **(726.1)** | (670.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Shareholders' Equity** | **3094.7** | 2826.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling Interest | **178.1** | 157.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Equity** | **3272.8** | 2984.1 |
| **Total Liabilities and Equity** | $**6813.9** | $6411.0 |

---

See accompanying Notes to the Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

**Consolidated Statements of Cash Flows**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
|  | **2025** | 2024 |
| (Dollars in millions) |  |  |
| **CASH PROVIDED (USED)** |  |  |
| **Operating Activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | $**177.1** | $212.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | **112.3** | 109.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairment charges | **—** | 1.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of assets | **(0.9)** | (1.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax benefit | **(0.7)** | (5.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | **14.4** | 11.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pension and other postretirement expense | **3.7** | 3.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pension and other postretirement benefit contributions and payments | **(28.4)** | (16.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | **(91.8)** | (131.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unbilled receivables | **(12.3)** | (3.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | **20.5** | (20.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable, trade | **23.0** | 13.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other accrued expenses | **(27.4)** | (20.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes | **(21.3)** | 31.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | **1.7** | (11.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net Cash Provided by Operating Activities** | **169.9** | 173.9 |
| **Investing Activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | **(68.3)** | (81.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from disposal of property, plant and equipment | **2.0** | 1.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investments in short-term marketable securities, net | **4.7** | 20.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | **—** | (0.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net Cash Used in Investing Activities** | **(61.6)** | (59.4) |
| **Financing Activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash dividends paid to shareholders | **(49.5)** | (48.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of treasury shares | **(45.7)** | (29.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from exercise of stock options | **0.5** | 5.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments related to tax withholding for stock-based compensation | **(9.8)** | (10.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Borrowings on accounts receivable facility | **239.0** | 55.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments on accounts receivable facility | **(239.0)** | (122.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from long-term debt | **46.0** | 1306.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments on long-term debt | **(53.3)** | (1221.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred financing costs | **—** | (5.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Short-term debt activity, net | **26.9** | (213.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from the sale of shares in Timken India Limited | **—** | 232.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | **—** | (1.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net Cash Used in Financing Activities** | **(84.9)** | (52.0) |
| Effect of exchange rate changes on cash | **23.8** | (10.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Increase in Cash, Cash Equivalents and Restricted Cash** | **47.2** | 51.7 |
| Cash, cash equivalents and restricted cash at beginning of year | **373.6** | 419.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Cash, Cash Equivalents and Restricted Cash at End of Period** | $**420.8** | $471.0 |

---

See accompanying Notes to the Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(Dollars in millions, except per share data)

*Note 1 - Basis of Presentation* 

The accompanying Consolidated Financial Statements (unaudited) for The Timken Company (the "Company" or "Timken") have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and notes required by the accounting principles generally accepted in the United States ("U.S. GAAP") for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) and disclosures considered necessary for a fair presentation have been included. For further information, refer to the Consolidated Financial Statements and accompanying Notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

*Note 2 - Significant Accounting Policies* 

The Company's significant accounting policies are detailed in "*Note 1 - Significant Accounting Policies"* of the Annual Report on Form 10-K for the year ended December 31, 2024.

**<u>Recent Accounting Pronouncements:</u>**

**New Accounting Guidance Issued and Not Yet Adopted:**

In November 2024, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2024-03, Income Statement—Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40). ASU 2024-03 requires that a public entity disclose the detailed information about types of expense. Specifically, a public entity would disclose the amounts of (a) purchases of inventory, (b) employee compensation, (c) depreciation and (d) intangible asset amortization included in each relevant expense caption. A relevant expense caption is an expense caption presented on the face of the income statement within continuing operations that contains any of the expense categories listed in (a)–(d). In addition, a public entity should include certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirements. A public entity would also disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively and disclose the total amounts of selling expenses and, in annual reporting periods, an entity's definition of selling expenses. For public entities, the new guidance is effective for annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The new guidance should be applied either prospectively to financial statements issued after the effective date of ASU 2024-03 or retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the impact of the new guidance.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740). ASU 2023-09 is intended to enhance the transparency and decision usefulness of income tax disclosures primarily related to the rate reconciliation and income taxes paid information. The amendments in this update require that public entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. The amendments require that all entities disclose on an annual basis the amount of income taxes paid disaggregated for federal, state, and foreign taxes and further disaggregated for specific jurisdictions to the extent the related amounts exceed a quantitative threshold. For public entities, the new guidance is effective for annual periods beginning after December 15, 2024. The Company is preparing to adopt the new disclosure requirements beginning with its Annual Report on Form 10-K for the year ending December 31, 2025.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 3 - Segment Information* 

The Company operates under two reportable segments: (1) Engineered Bearings and (2) Industrial Motion. The Company's Chief Operating Decision Maker ("CODM") is the President and Chief Executive Officer ("CEO"). The primary measurement used by the CODM to measure the financial performance of each segment is adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA"). The Company's CODM evaluates financial performance and allocates resources based on return on capital and profitable growth. The CODM considers actual and budgeted results provided on a regular basis for both segment's profit measures when making decisions about allocating capital and personnel to the segments.

The following tables provide segment financial information and a reconciliation of segment results to consolidated results:

For the three months ended June 30, 2025:

---

| | | | |
|:---|:---|:---|:---|
| | **Engineered Bearings** | **Industrial Motion** | **Total** |
| Net sales | $**777.4** | $**396.0** | $**1173.4** |
| Cost of products sold <sup>(1)</sup>  | **(546.0)** | **(265.1)** |  |
| Selling, general and administrative expenses <sup>(2)</sup> | **(103.2)** | **(70.8)** |  |
| Other segment items <sup>(3)</sup>  | **0.8** | **—** |  |
| Depreciation and amortization <sup>(4)</sup> | **24.4** | **12.5** |  |
| Adjusted EBITDA for reportable segments | $**153.4** | $**72.6** | $**226.0** |
| Unallocated corporate expense |  |  | **(17.8)** |
| Impairment, restructuring and reorganization charges |  |  | **(4.7)** |
| Gain on the sale of certain assets |  |  | **0.1** |
| CEO transition expenses |  |  | **(3.2)** |
| Depreciation and amortization |  |  | **(57.2)** |
| Interest expense |  |  | **(29.8)** |
| Interest income |  |  | **3.0** |
| Income before income taxes |  |  | $**116.4** |

---

For the six months ended June 30, 2025:

---

| | | | |
|:---|:---|:---|:---|
| | **Engineered Bearings** | **Industrial Motion** | **Total** |
| Net sales | $**1538.1** | $**775.6** | $**2313.7** |
| Cost of products sold <sup>(1)</sup>  | **(1069.3)** | **(521.7)** |  |
| Selling, general and administrative expenses <sup>(2)</sup> | **(205.7)** | **(138.8)** |  |
| Other segment items <sup>(3)</sup>  | **1.5** | **—** |  |
| Depreciation and amortization <sup>(4)</sup> | **48.0** | **24.6** |  |
| Adjusted EBITDA for reportable segments | $**312.6** | $**139.7** | $**452.3** |
| Unallocated corporate expense |  |  | **(36.0)** |
| Impairment, restructuring and reorganization charges |  |  | **(7.8)** |
| Gain on the sale of certain assets |  |  | **1.3** |
| CEO transition expenses |  |  | **(11.8)** |
| Depreciation and amortization |  |  | **(112.3)** |
| Interest expense |  |  | **(56.3)** |
| Interest income |  |  | **5.3** |
| Income before income taxes |  |  | $**234.7** |

---

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 3 - Segment Information (continued)*

For the three months ended June 30, 2024:

---

| | | | |
|:---|:---|:---|:---|
| | Engineered Bearings | Industrial Motion | Total |
| Net sales | $783.4 | $398.9 | $1182.3 |
| Cost of products sold <sup>(1)</sup>  | (538.0) | (266.0) |  |
| Selling, general and administrative expenses <sup>(2)</sup> | (105.5) | (64.1) |  |
| Other segment items <sup>(3)</sup>  | 2.5 | 0.1 |  |
| Depreciation and amortization <sup>(4)</sup> | 23.8 | 10.8 |  |
| Adjusted EBITDA for reportable segments | $166.2 | $79.7 | $245.9 |
| Unallocated corporate expense |  |  | (15.7) |
| Impairment, restructuring and reorganization charges |  |  | (4.7) |
| Acquisition-related charges |  |  | (3.0) |
| Gain on the sale of certain assets |  |  | 0.2 |
| CEO transition expenses |  |  | (1.1) |
| Depreciation and amortization |  |  | (54.2) |
| Interest expense |  |  | (34.6) |
| Interest income |  |  | 5.1 |
| Income before income taxes |  |  | $137.9 |

---

For the six months ended June 30, 2024:

---

| | | | |
|:---|:---|:---|:---|
| | Engineered Bearings | Industrial Motion | Total |
| Net sales | $1585.9 | $786.7 | $2372.6 |
| Cost of products sold <sup>(1)</sup>  | (1078.8) | (511.5) |  |
| Selling, general and administrative expenses <sup>(2)</sup> | (211.4) | (135.0) |  |
| Other segment items <sup>(3)</sup>  | 4.3 |  |  |
| Depreciation and amortization <sup>(4)</sup> | 47.6 | 21.6 |  |
| Adjusted EBITDA for reportable segments | $347.6 | $161.8 | $509.4 |
| Unallocated corporate expense |  |  | (32.8) |
| Impairment, restructuring and reorganization charges |  |  | (9.0) |
| Acquisition-related charges |  |  | (7.7) |
| Gain on the sale of certain assets |  |  | 0.9 |
| CEO transition expenses |  |  | (1.2) |
| Depreciation and amortization |  |  | (109.5) |
| Interest expense |  |  | (66.8) |
| Interest income |  |  | 7.9 |
| Income before income taxes |  |  | $291.2 |

---

<sup>(1)</sup> Cost of products sold exclude acquisition-related and reorganization charges.

<sup>(2)</sup> Selling, general, and administrative expenses exclude acquisition-related charges and CEO transition expenses.

<sup>(3)</sup> Other segment items is Other (expense) income, net and exclude the gain on the sale of certain assets.

<sup>(4)</sup> Depreciation and amortization excludes acquisition intangible amortization and depreciation recognized in reorganization charges, if any.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 3 - Segment Information (continued)*

The following tables provides additional segment financial information:

---

| | | |
|:---|:---|:---|
| | **June 30,<br>2025** | December 31, 2024 |
| Assets by Segment: |  |  |
| Engineered Bearings | $**3299.8** | $3126.1 |
| Industrial Motion | **3013.3** | 2822.6 |
| Corporate <sup>(5)</sup> | **500.8** | 462.3 |
|  | $**6813.9** | $6411.0 |

---

<sup>(5)</sup> Corporate assets include cash and cash equivalents and corporate buildings.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | 2024 | **2025** | 2024 |
| Capital expenditures: |  |  |  |  |
| Engineered Bearings | $**21.3** | $28.8 | $**46.2** | $63.3 |
| Industrial Motion | **11.8** | 8.4 | **22.0** | 17.8 |
| Corporate | **—** | 0.1 | **0.1** | 0.3 |
|  | $**33.1** | $37.3 | $**68.3** | $81.4 |
| Depreciation and amortization: |  |  |  |  |
| Engineered Bearings | $**27.5** | $26.8 | $**54.1** | $53.5 |
| Industrial Motion | **29.5** | 27.1 | **57.8** | 55.3 |
| Corporate | **0.2** | 0.3 | **0.4** | 0.7 |
|  | $**57.2** | $54.2 | $**112.3** | $109.5 |

---

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 4 - Revenue* 

The following table presents details deemed relevant to the users of the financial statements about total revenue for the three and six months ended June 30, 2025 and 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | Three Months Ended | Three Months Ended | Three Months Ended |
| | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | June 30, 2024 | June 30, 2024 | June 30, 2024 |
| | **Engineered Bearings** | **Industrial Motion** | **Total** | Engineered Bearings | Industrial Motion | Total |
| United States | $**319.7** | $**211.8** | $**531.5** | $335.9 | $203.5 | $539.4 |
| Americas excluding the <br> United States | **98.3** | **22.0** | **120.3** | 96.3 | 26.5 | 122.8 |
| Europe / Middle East / Africa | **148.6** | **136.3** | **284.9** | 151.0 | 135.2 | 286.2 |
| Asia-Pacific | **210.8** | **25.9** | **236.7** | 200.2 | 33.7 | 233.9 |
| Net sales | $**777.4** | $**396.0** | $**1173.4** | $783.4 | $398.9 | $1182.3 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | Six Months Ended | Six Months Ended | Six Months Ended |
| | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | June 30, 2024 | June 30, 2024 | June 30, 2024 |
| | **Engineered Bearings** | **Industrial Motion** | **Total** | Engineered Bearings | Industrial Motion | Total |
| United States | $**631.2** | $**414.1** | $**1045.3** | $671.0 | $396.2 | $1067.2 |
| Americas excluding the <br> United States | **186.5** | **43.2** | **229.7** | 191.0 | 51.1 | 242.1 |
| Europe / Middle East / Africa | **288.2** | **266.0** | **554.2** | 320.5 | 277.8 | 598.3 |
| Asia-Pacific | **432.2** | **52.3** | **484.5** | 403.4 | 61.6 | 465.0 |
| Net sales | $**1538.1** | $**775.6** | $**2313.7** | $1585.9 | $786.7 | $2372.6 |

---

When reviewing revenue by sales channel, the Company separates net sales to original equipment manufacturers ("OEMs") from sales to distributors and end users. The following table presents the approximate percent of revenue by sales channel for the six months ended June 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | Six Months Ended |
| Revenue by sales channel | **June 30, 2025** | June 30, 2024 |
| Original equipment manufacturers | **60%** | 60% |
| Distribution/direct to end users | **40%** | 40% |

---

In addition to disaggregating revenue by segment, geography and by sales channel as shown above, the Company believes information about the timing of transfer of goods or services and type of customer is also relevant. During the six months ended June 30, 2025 and June 30, 2024, approximately 9% and 7%, respectively, of total net sales were recognized over-time because of the continuous transfer of control to the customer, with the remainder recognized as of a point in time. Finally, business with the United States ("U.S.") government or its contractors represented approximately 7% and 6% of total net sales during the six months ended June 30, 2025 and June 30, 2024, respectively.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 4 - Revenue (continued)*

**Remaining Performance Obligations:**

Remaining performance obligations represent the transaction price of orders meeting the definition of a contract for which work has not been performed and excludes unexercised contract options. Performance obligations having a duration of more than one year are concentrated in contracts for certain products and services provided to the U.S. government or its contractors. The aggregate amount of the transaction price allocated to remaining performance obligations for such contracts with a duration of more than one year was approximately $234 million at June 30, 2025.

**Unbilled Receivables:**

The following table contains a rollforward of unbilled receivables for the six months ended June 30, 2025 and the twelve months ended December 31, 2024:

---

| | | |
|:---|:---|:---|
| | **June 30,<br>2025** | December 31,<br>2024 |
| Beginning balance, January 1 | $**140.8** | $144.5 |
| Additional unbilled revenue recognized | **180.6** | 380.5 |
| Less: amounts billed to customers | **(168.2)** | (384.2) |
| Ending balance | $**153.2** | $140.8 |

---

There were no impairment losses recorded on unbilled receivables for the six months ended June 30, 2025 and the twelve months ended December 31, 2024.

**Deferred Revenue:**

The following table contains a rollforward of deferred revenue for the six months ended June 30, 2025 and the twelve months ended December 31, 2024:

---

| | | |
|:---|:---|:---|
| | **June 30,<br>2025** | December 31,<br>2024 |
| Beginning balance, January 1 | $**41.4** | $45.4 |
| Acquisitions | **—** | 0.7 |
| Revenue received or billed in advance of recognition | **80.6** | 153.0 |
| Less: revenue recognized | **(76.3)** | (157.7) |
| Ending balance | $**45.7** | $41.4 |

---

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 5 - Income Taxes* 

The Company's provision for income taxes in interim periods is computed by applying the estimated annual effective tax rates to income or loss before income taxes for the period. In addition, non-recurring or discrete items are recorded during the period(s) in which they occur.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | 2024 | **2025** | 2024 |
| Provision for income taxes | $**30.7** | $35.9 | $**57.6** | $78.6 |
| Effective tax rate | **26.4%** | 26.0% | **24.5%** | 27.0% |

---

Income tax expense for the three and six months ended June 30, 2025 was calculated using forecasted multi-jurisdictional annual effective tax rates to determine a blended annual effective tax rate. The effective tax rate differs from the U.S. federal statutory rate of 21% due to the actual and projected mix of earnings in non-U.S. jurisdictions with relatively higher tax rates, U.S. state and local income taxes, and other permanent differences (net).

The effective tax rate of 26.4% for the three months ended June 30, 2025 was higher than the effective tax rate for the three months ended June 30, 2024 primarily due an increase in the mix of earnings in non-U.S. jurisdictions with relatively higher tax rates.

The effective tax rate of 24.5% for the six months ended June 30, 2025 was lower than the effective tax rate for the six months ended June 30, 2024 primarily due to the net favorable impact of discrete items in comparison to the year ago period. The favorable discrete items in the current period primarily related to the reversal of accruals for uncertain tax positions to account for the expiration of statues of limitations in jurisdictions outside the United States. This was partially offset by an increase in the mix of earnings in non-U.S. jurisdictions with relatively higher tax rates.

*Note 6 - Earnings Per Share*

The following table sets forth the reconciliation of the numerator and the denominator of basic earnings per share and diluted earnings per share for the three and six months ended June 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | 2024 | **2025** | 2024 |
| Numerator: |  |  |  |  |
| &nbsp;&nbsp;Net income attributable to The Timken Company | $**78.5** | $96.2 | $**156.8** | $199.7 |
| Denominator: |  |  |  |  |
| &nbsp;&nbsp;Weighted average number of shares outstanding - basic | **69751965** | 70364539 | **69877737** | 70301757 |
| &nbsp;&nbsp;Effect of dilutive securities: |  |  |  |  |
| &nbsp;&nbsp;Stock options and awards - based on the treasury<br> stock method | **323119** | 484715 | **406110** | 549035 |
| &nbsp;&nbsp;Weighted average number of shares outstanding assuming<br> dilution of stock options and awards | **70075084** | 70849254 | **70283847** | 70850792 |
| Basic earnings per share | $**1.13** | $1.37 | $**2.24** | $2.84 |
| Diluted earnings per share | $**1.12** | $1.36 | $**2.23** | $2.82 |

---

The dilutive effect of performance-based restricted stock units is taken into account once they have met minimum performance thresholds. The dilutive effect of stock options includes all outstanding stock options except stock options that are considered antidilutive. Stock options are antidilutive when the exercise price exceeds the average market price of the Company's common shares during the periods presented. There were no antidilutive stock options outstanding during the three and six months ended June 30, 2025 and 2024. In addition, there were 91,425 and 70,595 antidilutive stock awards, including performance-based restricted stock units and restricted stock units, outstanding during the three and six months ended June 30, 2025, respectively.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 7 - Inventories* 

The components of inventories at June 30, 2025 and December 31, 2024 were as follows:

---

| | | |
|:---|:---|:---|
| | **June 30,<br>2025** | December 31,<br>2024 |
| Manufacturing supplies | $**45.0** | $42.8 |
| Raw materials | **139.2** | 155.2 |
| Work in process | **495.8** | 476.0 |
| Finished products | **626.1** | 595.0 |
| &nbsp;&nbsp;&nbsp;&nbsp; Subtotal | **1306.1** | 1269.0 |
| Allowance for obsolete and surplus inventory | **(84.0)** | (73.4) |
| &nbsp;&nbsp;&nbsp;&nbsp; Total inventories, net | $**1222.1** | $1195.6 |

---

Inventories are valued at net realizable value, with approximately 60% valued on the first-in, first-out ("FIFO") method and the remaining 40% valued on the last-in, first-out ("LIFO") method. The majority of the Company's U.S. inventories are valued on the LIFO method. The Company's non-U.S. inventories are valued on the FIFO method.

The LIFO reserve as of June 30, 2025 and December 31, 2024 was $269.6 million and $257.2 million, respectively. An actual valuation of the inventory under the LIFO method can be made only at the end of each year based on the inventory levels and costs at that time. Accordingly, interim LIFO calculations are based on current inventory levels and costs. Because these calculations are subject to many factors beyond management's control, annual results may differ from interim results as they are subject to the final year-end LIFO inventory valuation.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 8 - Goodwill and Other Intangible Assets* 

The Company tests goodwill and indefinite-lived intangible assets for impairment at least annually, performing its annual impairment test as of October 1<sup>st</sup>. Goodwill and indefinite-lived intangible assets are also reviewed for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable.

The Company reviews goodwill for impairment at the reporting unit level. The Engineered Bearings segment has one reporting unit and the Industrial Motion segment has six reporting units.

The changes in the carrying amount of goodwill for the six months ended June 30, 2025 were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Engineered Bearings** | **Industrial Motion** | **Total** |
| Beginning balance, January 1 | $**692.0** | $**691.3** | $**1383.3** |
| Foreign currency translation adjustments and other changes | **13.3** | **91.4** | **104.7** |
| Ending balance | $**705.3** | $**782.7** | $**1488.0** |

---

The following table displays intangible assets as of June 30, 2025 and December 31, 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Balance at June 30, 2025** | **Balance at June 30, 2025** | **Balance at June 30, 2025** | Balance at December 31, 2024 | Balance at December 31, 2024 | Balance at December 31, 2024 |
| | **Gross<br>Carrying<br>Amount** | **Accumulated<br>Amortization** | **Net<br>Carrying<br>Amount** | Gross<br>Carrying<br>Amount | Accumulated<br>Amortization | Net<br>Carrying<br>Amount |
| Intangible assets <br>subject to amortization: |  |  |  |  |  |  |
| Customer relationships | $**864.2** | $**(297.6)** | $**566.6** | $805.7 | $(262.9) | $542.8 |
| Technology and know-how | **392.9** | **(140.3)** | **252.6** | 369.6 | (120.4) | 249.2 |
| Trade names | **116.9** | **(20.6)** | **96.3** | 107.5 | (16.9) | 90.6 |
| Capitalized software | **307.6** | **(281.5)** | **26.1** | 302.8 | (276.1) | 26.7 |
| Other | **10.6** | **(9.5)** | **1.1** | 11.0 | (9.8) | 1.2 |
|  | $**1692.2** | $**(749.5)** | $**942.7** | $1596.6 | $(686.1) | $910.5 |
| Intangible assets not subject to amortization: |  |  |  |  |  |  |
| Trade names | $**92.0** |  | $**92.0** | $87.3 |  | $87.3 |
| FAA air agency certificates | **8.7** |  | **8.7** | 8.7 |  | 8.7 |
|  | $**100.7** |  | $**100.7** | $96.0 |  | $96.0 |
| Total intangible assets | $**1792.9** | $**(749.5)** | $**1043.4** | $1692.6 | $(686.1) | $1006.5 |

---

Amortization expense for intangible assets was $42.9 million and $42.6 million for the six months ended June 30, 2025 and 2024, respectively. Amortization expense for intangible assets is projected to be approximately $88 million in 2025; $86 million in 2026; $83 million in 2027; $81 million in 2028; and $78 million in 2029.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 9 - Other Current Liabilities*

The following table displays other current liabilities as of June 30, 2025 and December 31, 2024:

---

| | | |
|:---|:---|:---|
| | **June 30,<br>2025** | December 31,<br>2024 |
| Sales rebates | $**57.4** | $69.2 |
| Deferred revenue | **45.7** | 41.4 |
| Operating lease liabilities | **32.4** | 32.0 |
| Taxes other than income and payroll taxes | **21.8** | 25.8 |
| Freight and duties | **20.1** | 14.3 |
| Product warranty | **17.4** | 18.0 |
| Unprocessed invoices | **15.0** | 15.1 |
| Professional fees | **13.3** | 11.5 |
| Interest | **13.0** | 25.3 |
| Current derivative liability | **9.1** | 10.4 |
| Restructuring | **6.9** | 3.7 |
| Other | **62.9** | 52.5 |
| **Total other current liabilities** | $**315.0** | $319.2 |

---

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 10 - Financing Arrangements* 

Short-term debt at June 30, 2025 and December 31, 2024 was as follows:

---

| | | |
|:---|:---|:---|
| | **June 30,<br>2025** | December 31,<br>2024 |
| Borrowings under lines of credit for certain of the Company's foreign subsidiaries with various banks with interest rates ranging from 2.58% to 3.03% at June 30, 2025 and 3.36% to 3.95% at December 31, 2024 | $**39.3** | $8.7 |
| Short-term debt | $**39.3** | $8.7 |

---

Lines of credit for certain of the Company's foreign subsidiaries provide for short-term borrowings. Most of these lines of credit are uncommitted. At June 30, 2025, the Company's foreign subsidiaries had borrowings outstanding of $39.3 million and bank guarantees of $0.2 million.

Long-term debt at June 30, 2025 and December 31, 2024 was as follows:

---

| | | |
|:---|:---|:---|
| | **June 30,<br>2025** | December 31,<br>2024 |
| Fixed-rate Euro Senior Unsecured Notes<sup>(1)</sup>, maturing on September 7, 2027,<br>&nbsp;&nbsp;&nbsp;&nbsp;with an interest rate of 2.02% | $**176.8** | $155.3 |
| Variable-rate Term Loan<sup>(1)</sup>, maturing on December 5, 2027, with an interest rate<br>&nbsp;&nbsp;&nbsp;&nbsp;of 5.55% at June 30, 2025 and 5.58% at December 31, 2024 | **364.7** | 369.6 |
| Fixed-rate Medium-Term Notes, Series A<sup>(1)</sup>, maturing at various dates through<br>&nbsp;&nbsp;&nbsp;&nbsp;May 2028, with interest rates ranging from 6.74% to 7.76% | **154.9** | 154.8 |
| Fixed-rate Senior Unsecured Notes<sup>(1)</sup>, maturing on December 15, 2028, with<br>&nbsp;&nbsp;&nbsp;&nbsp;an interest rate of 4.50% | **398.3** | 398.1 |
| Fixed-rate Senior Unsecured Notes<sup>(1)</sup>, maturing on April 1, 2032, with an<br>&nbsp;&nbsp;&nbsp;&nbsp;interest rate of 4.13% | **345.8** | 345.1 |
| Fixed-rate Euro Senior Unsecured Notes<sup>(1)</sup>, maturing on May 23, 2034, with an<br>&nbsp;&nbsp;&nbsp;&nbsp;interest rate of 4.13% | **696.9** | 609.7 |
| Fixed-rate Euro Bank Loan, maturing on June 30, 2033, with an <br>&nbsp;&nbsp;&nbsp;&nbsp;interest rate of 2.15% | **11.4** | 10.6 |
| Other | **10.2** | 10.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total debt | $**2159.0** | $2054.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: current maturities | **19.4** | 4.3 |
| Long-term debt | $**2139.6** | $2049.7 |

---

<sup>(1)</sup> *Net of discounts and fees* 

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 10 - Financing Arrangements (continued)*

The Company has a $100 million Amended and Restated Asset Securitization Agreement (the "Accounts Receivable Facility"), which matures on November 30, 2026. Under the terms of the Accounts Receivable Facility, the Company sells, on an ongoing basis, certain domestic trade receivables to Timken Receivables Corporation, a wholly-owned consolidated subsidiary that, in turn, uses the trade receivables to secure borrowings that are funded through a vehicle that issues commercial paper in the short-term market. Borrowings under the Accounts Receivable Facility may be limited by certain borrowing base limitations; however, availability under the Accounts Receivable Facility was not reduced by any such borrowing base limitations at June 30, 2025. As of June 30, 2025, there were no outstanding borrowings under the Accounts Receivable Facility. The cost of this facility, which is the prevailing commercial paper rate plus facility fees, is considered a financing cost and is included in interest expense in the Consolidated Statements of Income.

On December 5, 2022, the Company entered into the Fifth Amended and Restated Credit Agreement ("Credit Agreement"), which is comprised of a $750 million unsecured revolving credit facility ("Senior Credit Facility") and a $400 million unsecured term loan facility ("2027 Term Loan") that each mature on December 5, 2027. The interest rates under the Credit Agreement are based on Secured Overnight Financing Rate ("SOFR"). At June 30, 2025, the Company had no outstanding borrowings under the Senior Credit Facility. The Credit Agreement has two financial covenants: a consolidated net leverage ratio and a consolidated interest coverage ratio.

On May 23, 2024, the Company issued fixed-rate Euro senior unsecured notes ("2034 Notes") in the aggregate principal amount of €600 million with an interest rate of 4.13%, maturing on May 23, 2034. Proceeds from the 2034 Notes were used for the redemption of the Company's outstanding fixed-rate unsecured senior notes in the aggregate principal amount of $350 million that were due to mature on September 1, 2024 ("2024 Notes"), as well as the repayment of other debt outstanding at the time of issuance.

At June 30, 2025, the Company was in full compliance with all applicable covenants on its outstanding debt.

In the ordinary course of business, the Company utilizes standby letters of credit issued by financial institutions to guarantee certain obligations, most of which relate to certain insurance contracts and indirect taxes. At June 30, 2025, outstanding letters of credit totaled $60.0 million, most with expiration dates within 12 months.

The maturities of long-term debt (including $8.2 million of finance leases) subsequent to June 30, 2025 are as follows:

---

| | |
|:---|:---|
| **Year** | |
| 2025 | $3.0 |
| 2026 | 49.4 |
| 2027 | 535.4 |
| 2028 | 522.7 |
| 2029 | 2.4 |
| 2030 | 1.8 |
| Thereafter | 1061.0 |

---

The table above excludes $16.7 million of unamortized discounts and fees that are netted against long-term debt at June 30, 2025.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 11 - Supply Chain Financing*

The Company offers a supplier finance program with different financial institutions where suppliers may receive early payment from the financial institutions on invoices issued to the Company. The Company and each financial institution entered into arrangements whereby the Company pays the financial institution per the terms of any supplier invoice paid early under the program and pays an annual fee for the supplier finance platform subscription and related support. The Company or the financial institutions may terminate participation in the program with 90 days' written notice. The supplier finance programs are unsecured and are not guaranteed by the Company. The financial institutions enter into separate arrangements with suppliers directly to participate in the program. The Company does not determine the terms or conditions of such arrangements or participate in the transactions between the suppliers and the financial institutions. The supplier invoice terms under the program typically require payment in full within 90 days of the invoice date.

The following table is a rollforward of the outstanding obligations for the Company's supplier finance program for the six months ended June 30, 2025 and twelve months ended December 31, 2024:

---

| | | |
|:---|:---|:---|
| | **June 30,<br>2025** | **December 31,<br>2024** |
| Confirmed obligations outstanding, January 1 | $**16.7** | $21.3 |
| Invoices confirmed | **44.0** | 105.0 |
| Confirmed invoices paid | **(44.1)** | (109.6) |
| Confirmed obligations outstanding, ending balance | $**16.6** | $16.7 |

---

The obligations outstanding at June 30, 2025 and December 31, 2024 were included in accounts payable, trade on the Consolidated Balance Sheets.

*Note 12 - Contingencies* 

The Company is responsible for environmental remediation at various manufacturing facilities presently or formerly operated by the Company. In addition, as described further below, the Company, through one of its subsidiaries, has currently been identified as a potentially responsible party for investigation and remediation under the Comprehensive Environmental Response, Compensation and Liability Act, known as the Superfund, or similar state laws with respect to one location. Claims for investigation and remediation have been asserted against numerous other unrelated entities, which are believed to be financially solvent and are expected to fulfill their proportionate share of the obligation.

On December 28, 2004, the United States Environmental Protection Agency ("USEPA") sent Lovejoy, LLC ("Lovejoy") a Special Notice Letter that identified Lovejoy as a potentially responsible party, together with at least 12 unrelated parties, at the Ellsworth Industrial Park Site, Downers Grove, DuPage County, Illinois (the "Site"). The Company acquired Lovejoy in 2016. Lovejoy's Downers Grove property is situated within the Ellsworth Industrial Complex. The USEPA and the Illinois Environmental Protection Agency ("IEPA") allege there have been one or more releases or threatened releases of hazardous substances, including, but not limited to, a release or threatened release on or from Lovejoy's property at the Site. The relief sought by the USEPA and IEPA includes further investigation and potential remediation of the Site and reimbursement of response costs. Lovejoy's allocated share of future costs related to the Site, including for investigation and/or remediation, could be significant. All previously pending property damage and personal injury lawsuits against Lovejoy related to the Site were settled or dismissed prior to our acquisition of Lovejoy.

In addition, governmental authorities in the United States and the European Union, among others, are increasingly focused on regulating per- and polyfluoroalkyl substances ("PFAS"). PFAS regulations are applicable to portions of the Company's products, and conditions may develop, arise or be discovered that create potentially significant environmental compliance or remediation liabilities at certain of its facilities.

The Company had total environmental accruals of $4.7 million for various known environmental matters that are probable and reasonably estimable at June 30, 2025 and December 31, 2024, which includes the Lovejoy matter described above. These accruals were recorded based upon the best estimate of costs to be incurred considering the progress made in determining the magnitude of remediation costs, the timing and extent of remedial actions required by governmental authorities and the amount of the Company's liability in proportion to other responsible parties. The ultimate resolution of these matters could result in actual costs that exceed amounts accrued.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 12 - Contingencies* (continued)

**Legal Matter:**

On June 11, 2024, the Company's majority-owned subsidiary, Timken India Limited ("TIL"), received a government order claiming damages (penalties and interest) totaling approximately $12 million. The order relates to the closure of TIL's retirement trust for employees and subsequent transfer of trust assets to the government-administered Employees' Provident Fund Organization ("EFPO"). The order alleges that the surrender of trust assets did not follow applicable EFPO timing guidelines. TIL believes it fully complied with EFPO requirements and guidelines under the circumstances. TIL is disputing the merits of the order and has filed an appeal with the high court in India having jurisdiction over the matter. Management believes that relief will be provided to TIL once the matter is fully adjudicated; accordingly, no liability has been recorded. While no assurance can be given as to the ultimate outcome of this matter, the Company does not believe that the final resolution will have a material effect on the Company's consolidated financial position or liquidity; however, the effect of any future outcome may be material to the results of operations of any particular period in which costs, if any, are recognized.

**Product Warranties:**

In addition to the contingencies above, the Company provides limited warranties on certain of its products. The balances at the end of each respective period represent the best estimates of costs for existing and future claims for products that are still under warranty. The balances as of June 30, 2025 and December 31, 2024 primarily related to accruals for products sold into the automotive and wind energy sectors. Accrual estimates are based on actual claims and expected trends that continue to mature. In addition, the Company continues to evaluate other claims raised by certain customers with respect to the performance of bearings sold into the wind energy and automotive sectors. Management believes that the outcome of these claims will not have a material effect on the Company's consolidated financial position; however, the effect of a change in our assessment may be material to the results of operations of any particular period in which such change occurs.

The following is a rollforward of the consolidated product warranty accrual for the six months ended June 30, 2025 and twelve months ended December 31, 2024:

---

| | | |
|:---|:---|:---|
| | **June 30,<br>2025** | December 31,<br>2024 |
| Beginning balance, January 1 | $**18.0** | $15.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expense | **2.1** | 9.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments | **(2.7)** | (6.6) |
| Ending balance | $**17.4** | $18.0 |

---

The product warranty accrual at June 30, 2025 and December 31, 2024 was included in other current liabilities on the Consolidated Balance Sheets.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 13 - Equity* 

The following tables present the changes in the components of equity for the three and six months ended June 30, 2025 and 2024, respectively:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | The Timken Company Shareholders | The Timken Company Shareholders | The Timken Company Shareholders | The Timken Company Shareholders | The Timken Company Shareholders | |
| |<br>Total | Stated<br>Capital | Other<br>Paid-In<br>Capital | Retained Earnings | Accumulated<br>Other<br>Comprehensive<br>Loss | Treasury<br>Stock |<br>Non<br>controlling<br>Interest |
| Balance at March 31, 2025 | $3089.0 | $40.7 | $1277.1 | $2542.0 | $(238.9) | $(703.2) | $171.3 |
| Net income | 85.7 |  |  | 78.5 |  |  | 7.2 |
| Foreign currency translation adjustment | 143.6 |  |  |  | 144.0 |  | (0.4) |
| Pension and other postretirement liability<br>&nbsp;&nbsp;&nbsp;&nbsp;adjustments (net of income tax benefit<br>&nbsp;&nbsp;&nbsp;&nbsp;of $0.5 million) | (1.7) |  |  |  | (1.7) |  |  |
| Change in fair value of derivative financial <br> instruments, net of reclassifications | (3.6) |  |  |  | (3.6) |  |  |
| Dividends - $0.35 per share | (24.4) |  |  | (24.4) |  |  |  |
| Stock-based compensation expense | 6.9 |  | 6.9 |  |  |  |  |
| Stock purchased at fair market value | (22.6) |  |  |  |  | (22.6) |  |
| Stock option exercise activity | 0.2 |  | 0.2 |  |  |  |  |
| Payments related to tax withholding for<br> stock-based compensation | (0.3) |  |  |  |  | (0.3) |  |
| **Balance at June 30, 2025** | $**3272.8** | $**40.7** | $**1284.2** | $**2596.1** | $**(100.2)** | $**(726.1)** | $**178.1** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | The Timken Company Shareholders | The Timken Company Shareholders | The Timken Company Shareholders | The Timken Company Shareholders | The Timken Company Shareholders | |
| |<br>Total | Stated<br>Capital | Other<br>Paid-In<br>Capital | Retained Earnings | Accumulated<br>Other<br>Comprehensive<br>Loss | Treasury<br>Stock |<br>Non<br>controlling<br>Interest |
| Balance at December 31, 2024 | $2984.1 | $40.7 | $1269.3 | $2488.8 | $(301.7) | $(670.6) | $157.6 |
| Net income | 177.1 |  |  | 156.8 |  |  | 20.3 |
| Foreign currency translation adjustment | 210.7 |  |  |  | 210.5 |  | 0.2 |
| Pension and other postretirement liability<br>&nbsp;&nbsp;&nbsp;&nbsp;adjustments (net of income tax benefit<br>&nbsp;&nbsp;&nbsp;&nbsp;of $1.0 million) | (3.3) |  |  |  | (3.3) |  |  |
| Change in fair value of derivative financial <br> instruments, net of reclassifications | (5.7) |  |  |  | (5.7) |  |  |
| Dividends - $0.69 per share | (49.5) |  |  | (49.5) |  |  |  |
| Stock-based compensation expense | 14.4 |  | 14.4 |  |  |  |  |
| Stock purchased at fair market value | (45.7) |  |  |  |  | (45.7) |  |
| Stock option exercise activity | 0.5 |  | 0.5 |  |  |  |  |
| Payments related to tax withholding for<br> stock-based compensation | (9.8) |  |  |  |  | (9.8) |  |
| **Balance at June 30, 2025** | $**3272.8** | $**40.7** | $**1284.2** | $**2596.1** | $**(100.2)** | $**(726.1)** | $**178.1** |

---

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 13 - Equity (continued)*

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | The Timken Company Shareholders | The Timken Company Shareholders | The Timken Company Shareholders | The Timken Company Shareholders | The Timken Company Shareholders | |
| |<br>Total | Stated<br>Capital | Other<br>Paid-In<br>Capital | Retained Earnings | Accumulated<br>Other<br>Comprehensive<br>(Loss) | Treasury<br>Stock |<br>Non-<br>controlling<br>Interest |
| Balance at March 31, 2024 | $2735.0 | $40.7 | $1083.0 | $2311.2 | $(197.6) | $(629.0) | $126.7 |
| Net income | 102.0 |  |  | 96.2 |  |  | 5.8 |
| Foreign currency translation adjustment | (29.3) |  |  |  | (29.2) |  | (0.1) |
| Pension and other postretirement liability<br>&nbsp;&nbsp;&nbsp;&nbsp;adjustments (net of income tax benefit<br>&nbsp;&nbsp;&nbsp;&nbsp;of $0.4 million) | (1.5) |  |  |  | (1.5) |  |  |
| Change in fair value of derivative financial <br> instruments, net of reclassifications | (0.8) |  |  |  | (0.8) |  |  |
| Sale of shares of Timken India Limited | 188.0 |  | 162.5 |  | 5.6 |  | 19.9 |
| Noncontrolling interest acquired | 1.0 |  |  |  |  |  | 1.0 |
| Dividends - $0.34 per share | (23.9) |  |  | (23.9) |  |  |  |
| Stock-based compensation expense | 7.0 |  | 7.0 |  |  |  |  |
| Stock purchased at fair market value | (29.7) |  |  |  |  | (29.7) |  |
| Stock option exercise activity | 3.4 |  | 3.4 |  |  |  |  |
| Payments related to tax withholding for<br> stock-based compensation | (1.1) |  |  |  |  | (1.1) |  |
| Balance at June 30, 2024 | $2950.1 | $40.7 | $1255.9 | $2383.5 | $(223.5) | $(659.8) | $153.3 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | The Timken Company Shareholders | The Timken Company Shareholders | The Timken Company Shareholders | The Timken Company Shareholders | The Timken Company Shareholders | |
| |<br>Total | Stated<br>Capital | Other<br>Paid-In<br>Capital | Retained Earnings | Accumulated<br>Other<br>Comprehensive Loss | Treasury<br>Stock |<br>Non<br>controlling<br>Interest |
| Balance at December 31, 2023 | $2702.4 | $40.7 | $1076.5 | $2232.2 | $(146.9) | $(620.1) | $120.0 |
| Net income | 212.6 |  |  | 199.7 |  |  | 12.9 |
| Foreign currency translation adjustment | (80.0) |  |  |  | (79.5) |  | (0.5) |
| Pension and other postretirement liability<br>&nbsp;&nbsp;&nbsp;&nbsp;adjustments (net of income tax benefit<br>&nbsp;&nbsp;&nbsp;&nbsp;of $0.9 million) | (3.0) |  |  |  | (3.0) |  |  |
| Change in fair value of derivative financial <br> instruments, net of reclassifications | 0.3 |  |  |  | 0.3 |  |  |
| Dividends - $0.67 per share | (48.4) |  |  | (48.4) |  |  |  |
| Sale of shares of Timken India Limited | 188.0 |  | 162.5 |  | 5.6 |  | 19.9 |
| Noncontrolling interest acquired | 1.0 |  |  |  |  |  | 1.0 |
| Stock-based compensation expense | 11.5 |  | 11.5 |  |  |  |  |
| Stock purchased at fair market value | (29.7) |  |  |  |  | (29.7) |  |
| Stock option exercise activity | 5.4 |  | 5.4 |  |  |  |  |
| Payments related to tax withholding for<br> stock-based compensation | (10.0) |  |  |  |  | (10.0) |  |
| Balance at June 30, 2024 | $2950.1 | $40.7 | $1255.9 | $2383.5 | $(223.5) | $(659.8) | $153.3 |

---

On May 28, 2024, the Company completed the sale of 5.0 million shares of TIL, generating net proceeds of $188 million after income taxes of $44 million and transaction costs. The sale reduced the Company's ownership in TIL from 57.70 percent to 51.05 percent. The India market remains strategically important to Timken, and the Company is not planning on any further sale transactions.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 14 - Impairment and Restructuring Charges* 

Impairment and restructuring charges by segment are comprised of the following:

For the three months ended June 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Engineered Bearings** | **Industrial Motion** | **Unallocated Corporate** | **Total** |
| Severance and related benefit costs | $**0.9** | $**1.8** | $**—** | $**2.7** |
| Exit costs | **—** | **0.2** | **—** | **0.2** |
| **Total** | $**0.9** | $**2.0** | $**—** | $**2.9** |

---

For the six months ended June 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Engineered Bearings** | **Industrial Motion** | **Unallocated Corporate** | **Total** |
| Severance and related benefit costs | $**1.5** | $**2.5** | $**9.4** | $**13.4** |
| Exit costs | **—** | **0.4** | **—** | **0.4** |
| **Total** | $**1.5** | $**2.9** | $**9.4** | $**13.8** |

---

For the three months ended June 30, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Engineered Bearings | Industrial Motion | Unallocated Corporate | Total |
| Impairment charges | $1.9 | $— | $— | $1.9 |
| Severance and related benefit costs | 0.2 | 1.2 |  | 1.4 |
| Total | $2.1 | $1.2 | $— | $3.3 |

---

For the six months ended June 30, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Engineered Bearings | Industrial Motion | Unallocated Corporate | Total |
| Impairment charges | $1.9 | $— | $— | $1.9 |
| Severance and related benefit costs | 0.8 | 2.5 |  | 3.3 |
| Exit costs | 0.3 | 0.1 |  | 0.4 |
| Total | $3.0 | $2.6 | $— | $5.6 |

---

The following discussion explains the more significant impairment and restructuring charges recorded for the periods presented; however, it is not intended to reflect a comprehensive discussion of all amounts included in the tables above.

**Corporate:**

On March 31, 2025, Timken announced that the Company and Tarak B. Mehta, the President and CEO, had mutually agreed that Mr. Mehta would depart from the Company, including resigning as a member of the Company's Board of Directors (the "Board"), effective immediately. The Company also announced that the Board had appointed Richard G. Kyle as the interim President and CEO of the Company, effective immediately. Mr. Kyle currently serves as a member of the Board, and he previously acted as Advisor to the CEO of the Company from September 2024 until his retirement in February 2025 after having previously served as President and CEO of the Company from 2014 to 2024. During the three months ended March 31, 2025, the Company recorded severance expense of $9.3 million, plus related taxes, for Mr. Mehta's settlement arrangement and release of claims in connection with his termination without cause. Approximately two-thirds of this amount is expected to be paid in 2025, with the remaining amounts to be paid in 2026 and 2027.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 14 - Impairment and Restructuring Charges (continued)*

**Engineered Bearings:**

On February 20, 2025, the Company announced the closure of its bearing manufacturing plant in Hiddenite, North Carolina. This plant was part of the American Roller Bearing Company acquisition completed on January 31, 2023. The Company will transfer its operations to other bearing manufacturing facilities in the United States. The closure of this facility is expected to be completed during the first half of 2026 and is expected to affect approximately 60 employees. The Company expects to incur approximately $5 million to $7 million of pretax costs in total related to this closure. During the three and six months ended June 30, 2025, the Company recorded severance and related benefits of $0.4 million and $0.9 million, respectively, related to this closure. The Company has incurred cumulative pretax costs related to this closure of $3.6 million as of June 30, 2025, including rationalization costs recorded in cost of products sold.

During the three months ended June 30, 2024, the Company recorded impairment charges of $1.9 million related to

certain engineering-related assets used in the business. Management concluded no further investment would be made in these assets and as a result, reduced the value to $0.2 million.

**Industrial Motion:**

On December 6, 2024, the Company announced a reduction in force for its belts manufacturing facility in Springfield, Missouri. The reorganization of this facility is expected to affect approximately 100 employees and be completed during the first half of 2026. On November 30, 2023, the Company announced the closure of its belts manufacturing facility in Fort Scott, Kansas. The Company expects to transfer its operations to other belts manufacturing facilities. The closure of this facility is expected to be completed during the second half of 2025 and is expected to affect approximately 60 employees. The Company expects to incur approximately $12 million to $14 million of pretax costs in total related to the closure of the Fort Scott facility and the reorganization of the Springfield facility. During the three and six months ended June 30, 2025, the Company recorded severance and related benefit costs of $0.3 million and $0.7 million, respectively, related to these actions. During the three and six months ended June 30, 2024, the Company recorded severance and related benefits of $0.7 million and $1.5 million, respectively, related to these actions. The Company has incurred cumulative pretax costs related to these actions of $8.3 million as of June 30, 2025, including rationalization costs recorded in cost of products sold.

**Consolidated Restructuring Accrual:**

The following is a rollforward of the consolidated restructuring accrual for the six months ended June 30, 2025 and twelve months ended December 31, 2024:

---

| | | |
|:---|:---|:---|
| | **June 30,<br>2025** | December 31,<br>2024 |
| Beginning balance, January 1 | $**3.7** | $5.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expense | **13.8** | 9.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments | **(8.6)** | (12.0) |
| Ending balance | $**8.9** | $3.7 |

---

On the Consolidated Balance Sheet, $6.9 million of the restructuring accrual at June 30, 2025 was included in other current liabilities, with the remaining $2.0 million included in other non-current liabilities. The restructuring accrual at December 31, 2024 was included in other current liabilities on the Consolidated Balance Sheet.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 15 - Retirement Benefit Plans*

The following table sets forth the net periodic benefit cost for the Company's defined benefit pension plans. The amounts for the three and six months ended June 30, 2025 are based on calculations prepared by the Company's actuaries and represent the Company's best estimate of that period's proportionate share of the amounts to be recorded for the year ending December 31, 2025.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **U.S. Plans** | **U.S. Plans** | **International Plans** | **International Plans** | **Total** | **Total** |
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** |
| | **2025** | 2024 | **2025** | 2024 | **2025** | 2024 |
| Components of net periodic benefit<br> cost: |  |  |  |  |  |  |
| Service cost | $**0.1** | $0.3 | $**0.6** | $0.4 | $**0.7** | $0.7 |
| Interest cost | **4.4** | 4.2 | **2.8** | 2.6 | **7.2** | 6.8 |
| Expected return on plan assets | **(2.0)** | (1.9) | **(2.4)** | (2.4) | **(4.4)** | (4.3) |
| Amortization of prior service cost | **—** | 0.1 | **—** |  | **—** | 0.1 |
| &nbsp;&nbsp;Net periodic benefit cost | $**2.5** | $2.7 | $**1.0** | $0.6 | $**3.5** | $3.3 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **U.S. Plans** | **U.S. Plans** | **International Plans** | **International Plans** | **Total** | **Total** |
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | 2024 | **2025** | 2024 | **2025** | 2024 |
| Components of net periodic benefit<br> cost: |  |  |  |  |  |  |
| Service cost | $**0.3** | $0.4 | $**1.0** | $0.9 | $**1.3** | $1.3 |
| Interest cost | **8.7** | 8.5 | **5.5** | 5.1 | **14.2** | 13.6 |
| Expected return on plan assets | **(4.1)** | (3.8) | **(4.6)** | (4.8) | **(8.7)** | (8.6) |
| Amortization of prior service cost | **—** | 0.1 | **0.1** | 0.1 | **0.1** | 0.2 |
| &nbsp;&nbsp;Net periodic benefit cost | $**4.9** | $5.2 | $**2.0** | $1.3 | $**6.9** | $6.5 |

---

*Note 16 - Other Postretirement Benefit Plans* 

The following table sets forth the net periodic benefit cost for the Company's other postretirement benefit plans. The amounts for the three and six months ended June 30, 2025 are based on calculations prepared by the Company's actuaries and represent the Company's best estimate of that period's proportionate share of the amounts to be recorded for the year ending December 31, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | 2024 | **2025** | 2024 |
| Net periodic benefit credit: |  |  |  |  |
| Interest cost | $**0.4** | $0.4 | $**0.9** | $0.9 |
| Amortization of prior service credit | **(2.0)** | (2.0) | **(4.1)** | (4.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net periodic benefit credit | $**(1.6)** | $(1.6) | $**(3.2)** | $(3.2) |

---

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 17 - Accumulated Other Comprehensive Income (Loss)* 

The following tables present details about components of accumulated other comprehensive (loss) income for the three and six months ended June 30, 2025 and 2024, respectively:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Foreign currency translation adjustments | Pension and other postretirement liability adjustments | Change in fair value of derivative financial instruments | Total |
| Balance at March 31, 2025 | $(278.1) | $37.1 | $2.1 | $(238.9) |
| Other comprehensive income (loss) before<br> reclassifications and income taxes | 128.3 | (0.2) | (4.3) | 123.8 |
| Amounts reclassified from accumulated other<br> comprehensive loss before income<br> taxes |  | (2.0) | (0.7) | (2.7) |
| Income tax benefit | 15.3 | 0.5 | 1.4 | 17.2 |
| Net current period other comprehensive income<br> (loss), net of income taxes | 143.6 | (1.7) | (3.6) | 138.3 |
| Noncontrolling interest | 0.4 |  |  | 0.4 |
| Net current period other comprehensive income<br> (loss), net of income taxes and noncontrolling <br> interest | 144.0 | (1.7) | (3.6) | 138.7 |
| **Balance at June 30, 2025** | $**(134.1)** | $**35.4** | $**(1.5)** | $**(100.2)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Foreign currency translation adjustments | Pension and other postretirement liability adjustments | Change in fair value of derivative financial instruments | Total |
| Balance at December 31, 2024 | $(344.6) | $38.7 | $4.2 | $(301.7) |
| Other comprehensive loss (income) before<br> reclassifications and income taxes | 188.1 | (0.3) | (6.1) | 181.7 |
| Amounts reclassified from accumulated other<br> comprehensive loss before income taxes |  | (4.0) | (1.9) | (5.9) |
| Income tax benefit | 22.6 | 1.0 | 2.3 | 25.9 |
| Net current period other comprehensive loss,<br> net of income taxes | 210.7 | (3.3) | (5.7) | 201.7 |
| Noncontrolling interest | (0.2) |  |  | (0.2) |
| Net current period other comprehensive income <br> (loss), net of income taxes, noncontrolling<br> interest | 210.5 | (3.3) | (5.7) | 201.5 |
| **Balance at June 30, 2025** | $**(134.1)** | $**35.4** | $**(1.5)** | $**(100.2)** |

---

Foreign currency translation adjustments at June 30, 2025 and December 31, 2024 included cumulative losses of $44.1 million and cumulative gains of $27.1 million, respectively, net of deferred taxes, related to net investment hedges. Refer to Note 19 - Derivative Instruments and Hedging Activities for additional information on the net investment hedges.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 17 - Accumulated Other Comprehensive Income (Loss) (continued)*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Foreign currency translation adjustments | Pension and other postretirement liability adjustments | Change in fair value of derivative financial instruments | Total |
| Balance at March 31, 2024 | $(244.1) | $43.2 | $3.3 | $(197.6) |
| Sale of shares of Timken India Limited | $5.6 | $— | $— | $5.6 |
| Other comprehensive (loss) income before<br> reclassifications and income taxes | (29.3) |  | 0.7 | (28.6) |
| Amounts reclassified from accumulated other<br> comprehensive loss before income<br> taxes |  | (1.9) | (1.6) | (3.5) |
| Income tax benefit |  | 0.4 | 0.1 | 0.5 |
| Net current period other comprehensive loss,<br> net of income taxes | (29.3) | (1.5) | (0.8) | (31.6) |
| Noncontrolling interest | 0.1 |  |  | 0.1 |
| Net current period other comprehensive loss,<br> net of income taxes, noncontrolling <br> interest and sale of shares of Timken India<br> Limited | (23.6) | (1.5) | (0.8) | (25.9) |
| Balance at June 30, 2024 | $(267.7) | $41.7 | $2.5 | $(223.5) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Foreign currency translation adjustments | Pension and other postretirement liability adjustments | Change in fair value of derivative financial instruments | Total |
| Balance at December 31, 2023 | $(193.8) | $44.7 | $2.2 | $(146.9) |
| Sale of shares of Timken India Limited | 5.6 |  |  | 5.6 |
| Other comprehensive (loss) income before<br> reclassifications and income taxes | (80.0) |  | 2.4 | (77.6) |
| Amounts reclassified from accumulated other<br> comprehensive loss before income<br> taxes |  | (3.9) | (1.8) | (5.7) |
| Income tax benefit (expense) |  | 0.9 | (0.3) | 0.6 |
| Net current period other comprehensive (loss) <br> income, net of income taxes | (80.0) | (3.0) | 0.3 | (82.7) |
| Noncontrolling interest | 0.5 |  |  | 0.5 |
| Net current period other comprehensive (loss) <br> income, net of income taxes, noncontrolling <br> interest and sale of shares of Timken India<br> Limited | (73.9) | (3.0) | 0.3 | (76.6) |
| Balance at June 30, 2024 | $(267.7) | $41.7 | $2.5 | $(223.5) |

---

Other comprehensive (loss) income before reclassifications and income taxes includes the effect of foreign currency.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 18 - Fair Value* 

Fair value is defined as the price that would be expected to be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The FASB provides accounting rules that classify the inputs used to measure fair value into the following hierarchy:

Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities.

Level 2 – Unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.

Level 3 – Unobservable inputs for the asset or liability.

The following tables present the fair value hierarchy for those financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2025 and December 31, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
| | **Total** | **Level 1** | **Level 2** | **Level 3** |
| Assets: |  |  |  |  |
| Cash and cash equivalents | $**384.2** | $**381.8** | $**2.4** | $**—** |
| Cash and cash equivalents measured at net asset value | **35.1** |  |  |  |
| Restricted cash | **1.5** | **1.5** | **—** | **—** |
| Short-term investments | **11.4** | **—** | **11.4** | **—** |
| Foreign currency forward contracts | **3.2** | **—** | **3.2** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp; Total assets | $**435.4** | $**383.3** | $**17.0** | $**—** |
| Liabilities: |  |  |  |  |
| Foreign currency forward contracts | $**9.0** | $**—** | $**9.0** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp; Total liabilities | $**9.0** | $**—** | $**9.0** | $**—** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | December 31, 2024 | December 31, 2024 | December 31, 2024 | December 31, 2024 |
| | Total | Level 1 | Level 2 | Level 3 |
| Assets: |  |  |  |  |
| Cash and cash equivalents | $343.1 | $341.8 | $1.3 | $— |
| Cash and cash equivalents measured at net asset value | 30.1 |  |  |  |
| Restricted cash | 0.4 | 0.4 |  |  |
| Short-term investments | 15.9 |  | 15.9 |  |
| Foreign currency forward contracts | 4.9 |  | 4.9 |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Total assets | $394.4 | $342.2 | $22.1 | $— |
| Liabilities: |  |  |  |  |
| Foreign currency forward contracts | $10.4 | $— | $10.4 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp; Total liabilities | $10.4 | $— | $10.4 | $— |

---

Cash and cash equivalents include highly liquid investments with maturities of 90 days or less when purchased that are valued at redemption value. Short-term investments are investments with maturities between 91 days and one year, and generally are valued at amortized cost, which approximates fair value. A portion of the cash and cash equivalents and short-term investments are valued based on net asset value. The Company uses publicly available foreign currency forward and spot rates to measure the fair value of its foreign currency forward contracts.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 18 - Fair Value (continued)*

In addition, the Company remeasures certain assets at fair value, using Level 3 inputs, as a result of the occurrence of triggering events such as purchase accounting for acquisitions or goodwill impairment.

No material assets were measured at fair value on a nonrecurring basis during the six months ended June 30, 2025 and 2024.

**Financial Instruments:**

The Company's financial instruments consist primarily of cash and cash equivalents, short-term investments, accounts receivable, trade accounts payable, short-term borrowings and long-term debt. Due to their short-term nature, the carrying value of cash and cash equivalents, short-term investments, accounts receivable, trade accounts payable and short-term borrowings are a reasonable estimate of their fair value. Due to the nature of fair value calculations for variable-rate debt, the carrying value of the Company's long-term variable-rate debt is a reasonable estimate of its fair value. The fair value of the Company's long-term fixed-rate debt, based on Level 2 inputs (quoted market prices), was $1,780.0 million and $1,659.2 million at June 30, 2025 and December 31, 2024, respectively. The carrying value of this debt was $1,786.0 million and $1,675.6 million at June 30, 2025 and December 31, 2024, respectively. The difference between fair value and carrying value primarily reflects the net impact of changes in prevailing interest rates and credit spreads since the fixed-rate debt was issued.

The Company does not believe it has significant concentrations of risk associated with the counterparties to its financial instruments.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 19 - Derivative Instruments and Hedging Activities* 

The Company is exposed to certain risks relating to its ongoing business operations. The primary risks managed by using derivative instruments are foreign currency exchange rate risk and interest rate risk. Forward contracts on various foreign currencies are entered into in order to manage the foreign currency exchange rate risk associated with certain of the Company's commitments denominated in foreign currencies. From time to time, interest rate swaps are used to manage interest rate risk associated with the Company's fixed and floating-rate borrowings.

The Company designates certain foreign currency forward contracts as cash flow hedges of forecasted revenues and certain interest rate hedges as cash flow hedges of fixed-rate borrowings.

On May 23, 2024, the Company designated its 2034 Notes as a hedge against its net investment in one of its European subsidiaries. The objective of the hedge transaction is to protect the net investment in the foreign operations against changes in the exchange rate between the U.S. dollar and the Euro. The net impact for the three and six months ended June 30, 2025 was losses of $58.3 million and $86.0 million, respectively, recorded to accumulated other comprehensive (loss) income.

On September 15, 2020, the Company designated €54.5 million of its €150.0 million fixed-rate senior unsecured notes, maturing on September 7, 2027, as a hedge against its net investment in one of its European subsidiaries. The objective of the hedge transaction is to protect the net investment in the foreign operations against changes in the exchange rate between the U.S. dollar and the Euro. The net impact for the three and six months ended June 30, 2025 was losses of $5.3 million and $7.8 million, respectively, recorded to accumulated other comprehensive (loss) income.

The Company does not purchase or hold any derivative financial instruments for trading purposes. As of June 30, 2025 and December 31, 2024, the Company had $398.3 million and $471.6 million, respectively, of outstanding foreign currency forward contracts at notional value. Refer to Note 18 - Fair Value for the fair value disclosure of derivative financial instruments.

**Cash Flow Hedging Strategy:**

For certain derivative instruments that are designated and qualify as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same line item associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings.

To protect against a reduction in the value of forecasted foreign currency cash flows resulting from export sales, the Company has instituted a foreign currency cash flow hedging program. The Company hedges portions of its forecasted cash flows denominated in certain foreign currencies with forward contracts. When the dollar strengthens significantly against these foreign currencies, the decline in the present value of future foreign currency revenue is offset by gains in the fair value of the forward contracts designated as hedges. Conversely, when the dollar weakens, the increase in the present value of future foreign currency cash flows is offset by losses in the fair value of the forward contracts. As of June 30, 2025 and December 31, 2024, the Company had $70.6 million and $63.0 million, respectively, of outstanding foreign currency forward contracts at notional value that were classified as cash flow hedges.

The maximum length of time over which the Company hedges its exposure to the variability in future cash flows for forecast transactions is generally eighteen months.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*Note 19 - Derivative Instruments and Hedging Activities (continued)*

**Purpose for Derivative Instruments not designated as Hedging Instruments:**

For derivative instruments that are not designated as hedging instruments, the instruments are typically forward contracts. In general, the practice is to reduce volatility by selectively hedging transaction exposures including intercompany loans, accounts payable and accounts receivable. Intercompany loans between entities with different functional currencies typically are hedged with a forward contract at the inception of the loan with a maturity date corresponding to the maturity of the loan. The revaluation of these contracts, as well as the revaluation of the underlying balance sheet items, is recorded directly to the income statement so the adjustment generally offsets the revaluation of the underlying balance sheet items to protect cash payments and reduce income statement volatility.

As of June 30, 2025 and December 31, 2024, the Company had $327.7 million and $408.6 million, respectively, of outstanding foreign currency forward contracts at notional value that were not designated as hedging instruments. The following table presents the impact of derivative instruments not designated as hedging instruments for the three and six months ended June 30, 2025 and 2024, respectively, and the related location within the Consolidated Statements of Income:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | Amount of gain or (loss) recognized in income | Amount of gain or (loss) recognized in income | Amount of gain or (loss) recognized in income | Amount of gain or (loss) recognized in income |
| | | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| Derivatives not designated as hedging instruments: | Location of gain or (loss) recognized in income | **2025** | 2024 | **2025** | 2024 |
| Foreign currency forward contracts | Other expense, net | $**1.6** | $(3.9) | $**0.5** | $(10.0) |

---

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

(Dollars in millions, except per share data)

*OVERVIEW*

**Introduction:**

The Timken Company designs and manufactures a growing portfolio of engineered bearings and industrial motion products, and related services. With more than a century of knowledge and innovation, the Company continuously improves the reliability and efficiency of global machinery and equipment to move the world forward. The Company's growing product and services portfolio features many strong industrial brands, such as Timken®, GGB®, Philadelphia Gear®, Cone Drive®, Rollon®, Nadella®, Diamond®, Drives®, Groeneveld®, BEKA®, Des-Case®, Lovejoy® and Lagersmit®. Timken employs approximately 19,000 people globally in 45 countries. The Company operates under two reportable segments: (1) Engineered Bearings and (2) Industrial Motion. The following further describes these business segments:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Timken's Engineered Bearings segment features a broad range of product designs serving OEMs and end-users worldwide. Timken is a leading authority on tapered roller bearings and leverages its position by applying engineering know-how and technology across its entire bearing portfolio, which includes tapered, spherical and cylindrical roller bearings; plain bearings, metal-polymer bearings and rod end bearings; thrust and specialty ball bearings; and housed or mounted bearings. The Engineered Bearings portfolio features the Timken®, GGB® and Fafnir® brands and serves customers across global industries, including wind energy, agriculture, construction, food and beverage, metals and mining, automotive and truck, aerospace, rail and more.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Timken's Industrial Motion segment includes a diverse and growing portfolio of engineered products, including industrial drives, precision drives, automatic lubrication systems, linear motion products and systems, chains, belts, couplings, filtration systems, seals, and industrial clutches and brakes that keep systems running efficiently. Industrial Motion also includes industrial services, which return equipment and components to like-new condition. The Industrial Motion portfolio features many strong brands, including Philadelphia Gear®, Cone Drive®, Spinea®, Rollon®, Nadella®, Groeneveld®, BEKA®, Des-Case®, Diamond®, Drives®, Timken® Belts, Lovejoy®, PT Tech®, Lagersmit® and CGI. Industrial Motion products are used across a broad range of industries, including automation, solar energy, construction, agriculture and turf, passenger rail, marine, aerospace, packaging and logistics, medical and more.

Timken creates value by understanding customer needs and applying its know-how to serve a broad range of customers in attractive markets and industries across the globe. The Company's business strengths include its product technology, end-market diversity, geographic reach and aftermarket mix. Timken collaborates with OEMs to improve equipment efficiency with its engineered products and captures subsequent equipment replacement cycles by selling largely through independent channels in the aftermarket. Timken focuses its international efforts and footprint in regions of the world where strong macroeconomic factors such as urbanization, infrastructure development, industrialization and sustainability create demand for its products and services.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

**<u>The Company's strategy has three primary elements:</u>**

**Profitable Growth.** The Company intends to expand into new and existing markets by leveraging its collective knowledge of materials science, friction management and power transmission to create value for Timken customers. Using a customer-centric and highly collaborative technical selling approach, the Company places particular emphasis on creating unique solutions for challenging and/or demanding applications. The Company intends to grow in attractive market sectors around the world, emphasizing those spaces that are highly fragmented, demand high service and value the reliability and efficiency offered by Timken products. The Company also targets applications that offer significant aftermarket demand, thereby providing product and services revenue throughout the equipment's lifetime.

**Operational Excellence.** Timken operates with a relentless drive for exceptional results and a passion for superior execution. The Company embraces a continuous improvement culture that is charged with increasing efficiency, lowering costs, eliminating waste, increasing cash flow, driving organizational advancement and agility, and building greater brand equity to fuel growth. This requires the Company's ongoing commitment to attract, retain and develop the best talent across the world.

**Capital Deployment to Drive Shareholder Value.** The Company is focused on providing the highest returns for shareholders through its capital allocation framework, which includes: (1) investing in the core business through capital expenditures, research and development and initiatives to drive profitable organic growth; (2) pursuing strategic acquisitions to broaden its portfolio and capabilities across diverse markets, with a focus on engineered bearings, industrial motion products and related services; (3) returning capital to shareholders through dividends and share repurchases; and (4) maintaining a strong balance sheet and sufficient liquidity. As part of this framework, the Company may also restructure, reposition or divest underperforming product lines or assets.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

**Overview:**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | | |
| | **2025** | 2024 | $ Change | % Change |
| Net sales | $**1173.4** | $1182.3 | $(8.9) | (0.8%) |
| Net income | **85.7** | 102.0 | (16.3) | (16.0%) |
| Net income attributable to noncontrolling interest | **7.2** | 5.8 | 1.4 | 24.1% |
| Net income attributable to The Timken Company | $**78.5** | $96.2 | $(17.7) | (18.4%) |
| Diluted earnings per share | $**1.12** | $1.36 | $(0.24) | (17.6%) |
| Average number of shares – diluted | **70075084** | 70849254 |  | (1.1%) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | | |
| | **2025** | 2024 | $ Change | % Change |
| Net sales | $**2313.7** | $2372.6 | $(58.9) | (2.5)% |
| Net income | **177.1** | 212.6 | (35.5) | (16.7)% |
| Net income attributable to noncontrolling interest | **20.3** | 12.9 | 7.4 | 57.4% |
| Net income attributable to The Timken Company | $**156.8** | $199.7 | $(42.9) | (21.5)% |
| Diluted earnings per share | $**2.23** | $2.82 | $(0.59) | (20.9)% |
| Average number of shares – diluted | **70283847** | 70850792 |  | (0.8)% |

---

Net sales decreased for the three months ended June 30, 2025 compared with the three months ended June 30, 2024. The decrease was primarily driven by lower end-market demand in both segments, partially offset by favorable pricing, the benefit of acquisitions and the favorable impact of foreign currency exchange rate changes. Net sales decreased for the six months ended June 30, 2025 compared with the six months ended June 30, 2024. The decrease was primarily driven by lower end-market demand in both segments as well as the unfavorable impact of foreign currency exchange rate changes, partially offset by favorable pricing and the benefit of acquisitions.

Net income decreased for the three months ended June 30, 2025 compared with the three months ended June 30, 2024 primarily due to lower volume and incremental tariff costs, partially offset by favorable pricing. Net income decreased for the six months ended June 30, 2025 compared with the six months ended June 30, 2024 primarily due to lower volume, higher manufacturing costs, incremental tariff costs and higher restructuring costs, partially offset by lower income tax expense, favorable pricing and the benefit of acquisitions.

**Outlook:**

During the first half of 2025, the United States government announced the imposition of import tariffs on all countries. The baseline reciprocal tariff is 10%, with higher tariffs imposed on certain countries like China, Mexico and Canada, and sectors like steel, aluminum and automotive. The Company is taking steps to mitigate the increased costs from incremental tariffs through pricing, surcharges and other actions. Timken is also monitoring the impact that tariffs could have on global economic demand. The Company currently anticipates that tariffs and the related macroeconomic effects will adversely impact operating income in 2025.

As a result, the Company expects 2025 full-year revenues to be down 2.0% to 0.5% compared to 2024, primarily driven by lower demand across both segments, partially offset by favorable pricing and the benefit of acquisitions completed during 2024. The Company's earnings are expected to be down in 2025 compared with 2024, primarily due to the impact of lower organic sales volume, unfavorable mix, and incremental tariff costs, offset partially by favorable pricing, lower operating costs and the favorable impact of acquisitions.

The Company expects to generate a higher amount of cash from operating activities in 2025 compared to 2024, driven by improved working capital performance and lower cash taxes, partially offset by higher pension and other postretirement benefit contributions and payments. The Company expects capital expenditures in 2025 to be in the range of 3.5% of sales.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*THE STATEMENT OF INCOME*

**Operating Income:**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | | | |
| | **2025** | 2024 | $ Change | Change | Change |
| Net sales | $**1173.4** | $1182.3 | $(8.9) | (0.8%) | (0.8%) |
| Cost of products sold | **813.1** | 808.7 | 4.4 | 0.5% | 0.5% |
| Selling, general and administrative expenses | **189.7** | 184.1 | 5.6 | 3.0% | 3.0% |
| Amortization of intangible assets | **19.9** | 19.0 | 0.9 | 4.7% | 4.7% |
| Impairment and restructuring charges | **2.9** | 3.3 | (0.4) | (12.1%) | (12.1%) |
| Operating income | $**147.8** | $167.2 | (19.4) | (11.6%) | (11.6%) |
| Operating income % to net sales | **12.6%** | 14.1% |  | (150) | bps |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | | | |
| | **2025** | 2024 | $ Change | Change | Change |
| Net sales | $**2313.7** | $2372.6 | $(58.9) | (2.5%) | (2.5%) |
| Cost of products sold | **1594.7** | 1601.4 | (6.7) | (0.4%) | (0.4%) |
| Selling, general and administrative expenses | **374.5** | 374.8 | (0.3) | (0.1%) | (0.1%) |
| Amortization of intangible assets | **38.9** | 39.0 | (0.1) | (0.3%) | (0.3%) |
| Impairment and restructuring charges | **13.8** | 5.6 | 8.2 | 146.4% | 146.4% |
| Operating income | $**291.8** | $351.8 | (60.0) | (17.1%) | (17.1%) |
| Operating income % to net sales | **12.6%** | 14.8% |  | (220) | bps |

---

Net sales decreased for the three months ended June 30, 2025 compared with the three months ended June 30, 2024. The decrease was driven by lower organic revenue of $30 million, partially offset by the favorable impact of acquisitions of $14 million and the favorable impact of foreign currency exchange rate changes of $7 million. Net sales decreased for the six months ended June 30, 2025 compared with the six months ended June 30, 2024. The decrease was driven by lower organic revenue of $67 million and the unfavorable impact of foreign currency exchange rate changes of $19 million, partially offset by the favorable impact of acquisitions of $26 million.

Operating income decreased for the three months ended June 30, 2025 compared with the three months ended June 30, 2024, due to incremental cost of tariffs, the impact of lower volume and unfavorable mix, partially offset by favorable pricing, lower material and logistics costs and the benefit of acquisitions. Operating income decreased for the six months ended June 30, 2025 compared with the six months ended June 30, 2024, due to the impact of lower volume, unfavorable mix, higher manufacturing costs, incremental tariff costs, higher impairment and restructuring charges and the unfavorable impact of foreign currency exchange rate changes, partially offset by favorable pricing and the benefit of acquisitions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cost of products sold increased for the three months ended June 30, 2025 compared with the three months ended June 30, 2024, due to incremental tariff costs of $14 million, unfavorable foreign currency exchange rate changes of $7 million and the incremental cost of goods sold from acquisitions of $6 million, partially offset by the impact of lower production volume of $16 million and favorable material and logistics costs of $6 million. Cost of products sold decreased for the six months ended June 30, 2025 compared with the six months ended June 30, 2024, due to the impact of lower production volume of $24 million, favorable foreign currency exchange rate changes of $11 million and favorable material and logistics costs (net) of $4 million, partially offset by higher manufacturing costs of $7 million, incremental tariff costs of $15 million and incremental cost of goods sold from acquisitions of $10 million.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Selling, general and administrative ("SG&A") expenses increased for the three months ended June 30, 2025 compared with the three months ended June 30, 2024, primarily due to increased accruals for potential uncollectible accounts, the unfavorable impact from currency and the impact of acquisitions, partially offset by reduced discretionary spending to align with the lower demand levels. SG&A expenses were flat for the six months ended June 30, 2025 compared with the six months ended June 30, 2024 as the impact of acquisitions and increased accruals for potential uncollectible accounts were offset by reduced discretionary spending to align with lower demand levels.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*•* Impairment and restructuring charges were higher for the six months ended June 30, 2025 compared with the six months ended June 30, 2024, primarily due to severance related to the CEO transition during the six months ended June 30, 2025.

**Interest Income and Expense:**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | | |
| | **2025** | 2024 | $ Change | % Change |
| Interest expense | $**(29.8)** | $(34.6) | $4.8 | (13.9%) |
| Interest income | **3.0** | 5.1 | $(2.1) | (41.2%) |
| Interest expense, net | $**(26.8)** | $(29.5) | $2.7 | (9.2%) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | | |
| | **2025** | 2024 | $ Change | % Change |
| Interest expense | $**(56.3)** | $(66.8) | $10.5 | (15.7%) |
| Interest income | **5.3** | 7.9 | $(2.6) | (32.9)% |
| Interest expense, net | $**(51.0)** | $(58.9) | $7.9 | (13.4)% |

---

The decrease in interest expense for the three and six months ended June 30, 2025 compared with the three and six months ended June 30, 2024 was primarily due to lower average debt levels and lower interest rates.

**Other Income (Expense):**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | | |
| | **2025** | 2024 | $ Change | % Change |
| Non-service pension and other postretirement expense | $**(1.2)** | $(1.0) | $(0.2) | 20.0% |
| Other (expense) income | **(3.4)** | 1.2 | (4.6) | (383.3)% |
| Total other (expense) income | $**(4.6)** | $0.2 | $(4.8) | NM |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | | |
| | **2025** | 2024 | $ Change | % Change |
| Non-service pension and other postretirement expense | $**(2.4)** | $(2.0) | $(0.4) | 20.0% |
| Other (expense) income | **(3.7)** | 0.3 | (4.0) | NM |
| Total other expense, net | $**(6.1)** | $(1.7) | $(4.4) | 258.8% |

---

The change in other (expense) income, net, for the three and six months ended June 30, 2025 compared with the three and six months ended June 30, 2024 was primarily driven by the unfavorable impact of foreign currency exchange losses.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

**Income Tax Expense:**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | | | |
| | **2025** | 2024 | $ Change | Change | Change |
| Provision for income taxes | $**30.7** | $35.9 | $(5.2) | (14.5 | %) |
| Effective tax rate | **26.4%** | 26.0% |  | 40 | bps |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | | | |
| | **2025** | 2024 | $ Change | Change | Change |
| Provision for income taxes | $**57.6** | $78.6 | $(21.0) | (26.7) | % |
| Effective tax rate | **24.5%** | 27.0% |  | (250) | bps |

---

Income tax expense decreased $5.2 million for the three months ended June 30, 2025 compared with the three months ended June 30, 2024 primarily due to lower pre-tax earnings.

Income tax expense decreased $21.0 million for the six months ended June 30, 2025 compared with the six months ended June 30, 2024 primarily due to lower pre-tax earnings and the net favorable impact of discrete items in comparison to the year ago period. The favorable discrete items in the six months ended June 30, 2025 primarily related to the reversal of accruals for uncertain tax positions to account for the expiration of statutes of limitation in jurisdictions outside the United States.

On July 4, 2025, the One Big Beautiful Bill Act ("OBBBA") was enacted in the U.S. The OBBBA includes significant provisions, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act of 2017, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions. The legislation has multiple effective dates, with certain provisions effective in 2025 and others implemented through future years. The Company is currently assessing the impact of OBBBA on its Consolidated Financial Statements.

Refer to Note 5 - Income Taxes in the Notes to the Consolidated Financial Statements for more information on the computation of the income tax expense in interim periods.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*BUSINESS SEGMENTS*

The Company's reportable segments are product-based business groups that serve customers in diverse industrial markets. The primary measurement used by management to measure the financial performance of each segment is adjusted EBITDA. Refer to *Note 3 - Segment Information* in the Notes to the Consolidated Financial Statements for the reconciliation of adjusted EBITDA by segment to consolidated income before income taxes.

The presentation of segment results below includes a reconciliation of the changes in net sales for each segment reported in accordance with U.S. GAAP to net sales adjusted to remove the effects of the acquisitions completed in 2024 and foreign currency exchange rate changes. The effects of acquisitions and foreign currency exchange rate changes on net sales are removed to allow investors and the Company to meaningfully evaluate the percentage change in net sales on a comparable basis from period to period.

The following item highlights the Company's acquisition completed in 2024:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company acquired CGI, Inc. ("CGI") during the third quarter of 2024. Results for CGI are reported in the Industrial Motion segment.

**Engineered Bearings Segment:**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | | | |
| | **2025** | 2024 | $ Change | Change | Change |
| Net sales | $**777.4** | $783.4 | $(6.0) | (0.8 | %) |
| Cost of products sold | **(546.0)** | (538.0) | (8.0) | 1.5 | % |
| Selling, general and administrative expenses | **(103.2)** | (105.5) | 2.3 | (2.2 | %) |
| Other segment items | **0.8** | 2.5 | (1.7) | (68.0 | %) |
| Depreciation and amortization | **24.4** | 23.8 | 0.6 | 2.5 | % |
| Adjusted EBITDA | $**153.4** | $166.2 | $(12.8) | (7.7 | %) |
| Adjusted EBITDA margin | **19.7%** | 21.2% |  | (150) | bps |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | | |
| | **2025** | 2024 | $ Change | % Change |
| Net sales | $**777.4** | $783.4 | $(6.0) | (0.8%) |
| Less: Currency | **0.2** |  | 0.2 | NM |
| Net sales, excluding the impact of currency | $**777.2** | $783.4 | $(6.2) | (0.8%) |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | | | |
| | **2025** | 2024 | $ Change | Change | Change |
| Net sales | $**1538.1** | $1585.9 | $(47.8) | (3.0 | %) |
| Cost of products sold | **(1069.3)** | (1078.8) | 9.5 | (0.9 | %) |
| Selling, general and administrative expenses | **(205.7)** | (211.4) | 5.7 | (2.7 | %) |
| Other segment items | **1.5** | 4.3 | (2.8) | (65.1 | %) |
| Depreciation and amortization | **48.0** | 47.6 | 0.4 | 0.8 | % |
| Adjusted EBITDA | $**312.6** | $347.6 | $(35.0) | (10.1 | %) |
| Adjusted EBITDA margin | **20.3%** | 21.9% |  | (160) | bps |

---

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | | |
| | **2025** | 2024 | $ Change | % Change |
| Net sales | $**1538.1** | $1585.9 | $(47.8) | (3.0%) |
| Less: Currency | **(19.2)** |  | (19.2) | NM |
| Net sales, excluding the impact of currency | $**1557.3** | $1585.9 | $(28.6) | (1.8%) |

---

The Engineered Bearings segment's net sales, excluding the effects of foreign currency exchange rate changes, decreased $6.2 million or 0.8% in the three months ended June 30, 2025 compared with the three months ended June 30, 2024. The decrease was primarily driven by lower demand across most market sectors, partially offset by higher renewable energy demand and higher pricing. Adjusted EBITDA for the Engineered Bearings segment decreased for the three months ended June 30, 2025 by $12.8 million or 7.7% compared with the three months ended June 30, 2024, due to the unfavorable impact of tariffs, lower volume, unfavorable mix, higher manufacturing costs, and unfavorable foreign currency exchange rate changes, partially offset by favorable pricing and lower material and logistics costs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cost of products sold increased for the three months ended June 30, 2025 compared with the three months ended June 30, 2024 due to incremental tariff costs of $11 million, unfavorable foreign currency exchange rate changes and higher manufacturing costs, partially offset by lower material and logistics costs of $5 million and the impact of lower production volume.

The Engineered Bearings segment's net sales, excluding the effects of foreign currency exchange rate changes, decreased $28.6 million or 1.8% in the six months ended June 30, 2025 compared with the six months ended June 30, 2024. The decrease was primarily driven by lower demand across most market sectors, with the auto/truck, heavy industries and off-highway sectors posting the largest declines, partially offset by higher renewable energy demand. Adjusted EBITDA for the Engineered Bearings segment decreased for the six months ended June 30, 2025 by $35.0 million or 10.1% compared with the six months ended June 30, 2024, due to the impact of lower volume, the unfavorable impact of tariffs and unfavorable foreign currency exchange rate changes, partially offset by lower SG&A expenses and lower material and logistics costs (net).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cost of products sold decreased for the six months ended June 30, 2025 compared with the six months ended June 30, 2024 due to favorable foreign currency exchange rate changes of $12 million, the impact of lower production volume of $7 million and lower material and logistics costs (net) of $4 million, partially offset by incremental tariff costs of $12 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• SG&A expenses decreased for the six months ended June 30, 2025 compared with the six months ended June 30, 2024 driven primarily by lower compensation expense.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

**Industrial Motion Segment:**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | | | |
| | **2025** | 2024 | $ Change | Change | Change |
| Net sales | $**396.0** | $398.9 | $(2.9) | (0.7 | %) |
| Cost of products sold | **(265.1)** | (266.0) | 0.9 | (0.3 | %) |
| Selling, general and administrative expenses | **(70.8)** | (64.1) | (6.7) | 10.5 | % |
| Other segment items | **—** | 0.1 | (0.1) | (100.0 | %) |
| Depreciation and amortization | **12.5** | 10.8 | 1.7 | 15.7 | % |
| Adjusted EBITDA | $**72.6** | $79.7 | $(7.1) | (8.9 | %) |
| Adjusted EBITDA margin | **18.3%** | 20.0% |  | (170) | bps |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | | |
| | **2025** | 2024 | $ Change | % Change |
| Net sales | $**396.0** | $398.9 | $(2.9) | (0.7%) |
| Less: Acquisitions | **14.0** |  | 14.0 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Currency | **6.4** |  | 6.4 | NM |
| Net sales, excluding the impact of acquisitions<br> and currency | $**375.6** | $398.9 | $(23.3) | (5.8%) |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | | | |
| | **2025** | 2024 | $ Change | Change | Change |
| Net sales | $**775.6** | $786.7 | $(11.1) | (1.4 | %) |
| Cost of products sold | **(521.7)** | (511.5) | (10.2) | 2.0 | % |
| Selling, general and administrative expenses | **(138.8)** | (135.0) | (3.8) | 2.8 | % |
| Depreciation and amortization | **24.6** | 21.6 | 3.0 | 13.9 | % |
| Adjusted EBITDA | $**139.7** | $161.8 | $(22.1) | (13.7 | %) |
| Adjusted EBITDA margin | **18.0%** | 20.6% |  | (260) | bps |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | | |
| | **2025** | 2024 | $ Change | % Change |
| Net sales | $**775.6** | $786.7 | $(11.1) | (1.4%) |
| Less: Acquisitions | **26.3** |  | 26.3 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Currency | **0.7** |  | 0.7 | NM |
| Net sales, excluding the impact of acquisitions<br> and currency | $**748.6** | $786.7 | $(38.1) | (4.8)% |

---

The Industrial Motion segment's net sales, excluding the effects of acquisitions and foreign currency exchange rate changes, decreased $23.3 million or 5.8% in the three months ended June 30, 2025 compared with the three months ended June 30, 2024. The decrease reflects lower demand across most platforms, with belts and chain and lubrication systems experiencing the largest declines. Adjusted EBITDA decreased $7.1 million or 8.9% for the three months ended June 30, 2025 compared with the three months ended June 30, 2024 primarily due to the impact of lower volume, partially offset by favorable pricing and the benefit of acquisitions.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cost of products sold decreased for the three months ended June 30, 2025 compared with the three months ended June 30, 2024 due to the impact of lower production volume of $14 million, offset by incremental cost of goods sold from acquisitions of $9 million, unfavorable foreign currency exchange rate changes of $5 million and incremental tariff costs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• SG&A expenses increased for the three months ended June 30, 2025 compared with the three months ended June 30, 2024 primarily due to increased accruals for potential uncollectible accounts, as well as incremental SG&A expense from acquisitions.

The Industrial Motion segment's net sales, excluding the effects of acquisitions and foreign currency exchange rate changes, decreased $38.1 million or 4.8% in the six months ended June 30, 2025 compared with the six months ended June 30, 2024. The decrease reflects lower demand across most platforms, with belts and chain, industrial services and lubrication systems experiencing the largest declines, partially offset by growth in the drive systems platform. Adjusted EBITDA decreased $22.1 million or 13.7% for the six months ended June 30, 2025 compared with the six months ended June 30, 2024 due to the impact of lower volume, unfavorable mix and higher manufacturing costs, partially offset by higher pricing and the benefit of acquisitions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cost of products sold increased for the six months ended June 30, 2025 compared with the six months ended June 30, 2024 due to the incremental cost of goods sold from acquisitions of $17 million, higher manufacturing costs of $5 million and incremental tariff costs, partially offset by the impact of lower production volume of $17 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• SG&A expenses increased for the six months ended June 30, 2025 compared with the six months ended June 30, 2024 primarily due to increased accruals for potential uncollectible accounts, as well as the incremental SG&A expense from acquisitions, partly offset by reduced discretionary spending.

**Unallocated Corporate**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | | | |
| | **2025** | 2024 | $ Change | Change | Change |
| Unallocated corporate expense | $**(17.8)** | $(15.7) | $(2.1) | 13.4 | % |
| Unallocated corporate expense % to net sales | **(1.5** **%)** | (1.3%) |  | (20) | bps |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | | | |
| | **2025** | 2024 | $ Change | Change | Change |
| Unallocated corporate expense | $**(36.0)** | $(32.8) | $(3.2) | 9.8 | % |
| Unallocated corporate expense % to net sales | **(1.6)%** | (1.4)% |  | (20) | bps |

---

Unallocated corporate expense increased for the three and six months ended June 30, 2025 compared with the three and six months ended June 30, 2024 primarily due to unfavorable foreign currency exchange rate changes.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*CASH FLOW*

---

| | | | |
|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | |
| | **2025** | 2024 | $ Change |
| Net cash provided by operating activities | $**169.9** | $173.9 | $(4.0) |
| Net cash used in investing activities | **(61.6)** | (59.4) | (2.2) |
| Net cash used in financing activities | **(84.9)** | (52.0) | (32.9) |
| Effect of exchange rate changes on cash | **23.8** | (10.8) | 34.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase in cash and cash equivalents<br> and restricted cash | $**47.2** | $51.7 | $(4.5) |

---

*<u>Op</u><u>erating Activities:</u>*

The decrease in net cash provided by operating activities for the first six months of 2025 compared with the first six months of 2024 was due to the unfavorable impact of income taxes on cash of $48.5 million, a decrease in net income of $35.5 million and higher pension and postretirement payments of $12.3 million, largely offset by the favorable impact of working capital items of $74.3 million and other items. Refer to the tables below for additional detail of the impact of each line item on net cash provided by operating activities.

The following table displays the impact of working capital items on cash during the first six months of 2025 and 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | |
| | **2025** | 2024 | $ Change |
| Cash (used in) provided by: |  |  |  |
| Accounts receivable | $**(91.8)** | $(131.2) | $39.4 |
| Unbilled receivables | **(12.3)** | (3.8) | (8.5) |
| Inventories | **20.5** | (20.6) | 41.1 |
| Trade accounts payable | **23.0** | 13.8 | 9.2 |
| Other accrued expenses | **(27.4)** | (20.5) | (6.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash used in working capital items | $**(88.0)** | $(162.3) | $74.3 |

---

The following table displays the impact of income taxes on cash during the first six months of 2025 and 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | |
| | **2025** | 2024 | $ Change |
| Accrued income tax expense | $**57.6** | $78.6 | $(21.0) |
| Income tax payments | **(79.9)** | (51.8) | (28.1) |
| Other items | **0.3** | (0.3) | 0.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in income taxes | $**(22.0)** | $26.5 | $(48.5) |

---

*<u>Investing Activities:</u>*

The increase in net cash used in investing activities for the first six months of 2025 compared with the first six months of 2024 was due to a decrease in cash from the net liquidation of short-term marketable securities of $16.1 million, partially offset by lower capital expenditures of $13.1 million.

*<u>Financing Activities:</u>*

The change in net cash used in financing activities for the first six months of 2025 compared with the first six months of 2024 was due to the proceeds from the sale of shares of TIL of $232.3 million in 2024, as well as an increase in the purchase of treasury shares of $16.0 million, partially offset by a favorable change in debt borrowings/payments of $214.5 million.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*LIQUIDITY AND CAPITAL RESOURCES*

Reconciliation of total debt to net debt and the ratio of net debt to capital:

**Net Debt:**

---

| | | |
|:---|:---|:---|
| | **June 30,<br>2025** | December 31,<br>2024 |
| Short-term debt, including current portion of long-term debt | $**58.7** | $13.0 |
| Long-term debt | **2139.6** | 2049.7 |
| Total debt | $**2198.3** | $2062.7 |
| Less: Cash and cash equivalents | **419.3** | 373.2 |
| Net debt | $**1779.0** | $1689.5 |

---

**Ratio of Net Debt to Capital:**

---

| | | |
|:---|:---|:---|
| | **June 30,<br>2025** | December 31,<br>2024 |
| Net debt | $**1779.0** | $1689.5 |
| Total equity | **3272.8** | 2984.1 |
| Net debt plus total equity (capital) | $**5051.8** | $4673.6 |
| Ratio of net debt to capital | **35.2%** | 36.1% |

---

The Company presents net debt because it believes net debt is more representative of the Company's financial position than total debt due to the amount of cash and cash equivalents held by the Company and the ability to utilize such cash and cash equivalents to reduce debt if needed.

At June 30, 2025, the Company had strong liquidity with $419.3 million of cash and cash equivalents on the Consolidated Balance Sheet, as well as $850.0 million available under committed credit lines. Of the $419.3 million of cash and cash equivalents, $395.5 million resided in jurisdictions outside the United States. Repatriation of non-U.S. cash could be subject to taxes and some portion may be subject to governmental restrictions. Part of the Company's strategy is to grow in attractive market sectors, many of which are outside the United States. This strategy includes making investments in facilities, equipment and potential new acquisitions. The Company plans to fund these investments, as well as meet working capital requirements, with cash and cash equivalents and unused lines of credit within the geographic location of these investments where feasible.

On December 5, 2022, the Company entered into the Credit Agreement, which is comprised of a $750.0 million Senior Credit Facility and a $400.0 million 2027 Term Loan that each mature on December 5, 2027. The interest rates under the Credit Agreement are based on SOFR for U.S. dollar borrowings. At June 30, 2025, the Company had no outstanding borrowings under the Senior Credit Facility. The Credit Agreement has two defined financial covenants: a consolidated net leverage ratio and a consolidated interest coverage ratio. The maximum consolidated net leverage ratio permitted under the Senior Credit Facility is 3.5 to 1.0. As of June 30, 2025, the Company's consolidated net leverage ratio was 2.27 to 1.0. The minimum consolidated interest coverage ratio permitted under the Senior Credit Facility is 3.0 to 1.0. As of June 30, 2025, the Company's consolidated interest coverage ratio was 7.66 to 1.0.

The interest rate under the Senior Credit Facility is variable with a spread based on the Company's debt rating. The average rate on outstanding U.S. dollar borrowings was 5.76% over the quarter ending June 30, 2025. There were no Euro borrowings during the quarter. In addition, the Company pays a facility fee based on the applicable rate, which is variable with a spread based on the Company's debt rating, multiplied by the aggregate commitments of all of the lenders under the Senior Credit Facility. As of June 30, 2025, the Company carried investment-grade credit ratings with both Moody's (Baa2) and S&P Global (BBB-).

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

The Company has a $100 million Accounts Receivable Facility, which matures on November 30, 2026. The Accounts Receivable Facility is subject to certain borrowing base limitations and is secured by certain domestic trade accounts receivable of the Company. The Accounts Receivable Facility had no borrowing base limitations at June 30, 2025. As of June 30, 2025, the Company had no outstanding borrowings under the Accounts Receivable Facility.

Other sources of liquidity include uncommitted short-term lines of credit for certain of the Company's foreign subsidiaries, which currently provide for borrowings of up to $249.0 million. At June 30, 2025, the Company had borrowings outstanding of $39.3 million and bank guarantees of $0.2 million, which reduced the aggregate availability under these facilities to $209.5 million.

On May 23, 2024, the Company issued the 2034 Notes in the aggregate principal amount of €600 million with an interest rate of 4.13%, maturing on May 23, 2034. Proceeds from the 2034 Notes were used for the redemption of the 2024 Notes in the aggregate principal amount of $350 million that were due to mature on September 1, 2024, as well as the repayment of other debt outstanding at the time of the issuance.

At June 30, 2025, the Company was in full compliance with all applicable covenants on its outstanding debt.

The Company expects to generate a higher amount of cash from operating activities in 2025 compared to 2024, driven by improved working capital performance and lower cash taxes, partially offset by higher pension and other postretirement benefit contributions and payments. The Company expects capital expenditures in 2025 to be in the range of 3.5% of sales.

**Financing Obligations and Other Commitments:**

During the first six months of 2025, the Company made cash contributions and payments of $27.3 million to its global defined benefit pension plans and $1.1 million to its other postretirement benefit plans. In 2025, the Company expects to make contributions to its global defined benefit pension plans of approximately $36 million and to make payments of approximately $3 million to its other postretirement benefit plans. Excluding actuarial gains and losses, the Company expects higher pension and other postretirement benefits expense in 2025 compared to 2024 primarily due to lower expected returns on pension plan assets and higher interest expense.

The Company does not have any off-balance sheet arrangements with unconsolidated entities or other persons.

*CRITICAL ACCOUNTING POLICIES AND ESTIMATES*

The Company's financial statements are prepared in accordance with U.S. GAAP. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The Company reviews its critical accounting policies throughout the year. The Company has concluded that there have been no significant changes to its critical accounting policies or estimates, as described in its Annual Report on Form 10-K for the year ended December 31, 2024, during the six months ended June 30, 2025.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*OTHER MATTERS*

**Foreign Currency:**

Assets and liabilities of subsidiaries are translated at the rate of exchange in effect on the balance sheet date; income and expenses are translated at the average rates of exchange prevailing during the reporting period. Related translation adjustments are reflected as a separate component of accumulated other comprehensive loss. Foreign currency gains and losses resulting from transactions, and the related hedging activity, are included in the Consolidated Statements of Income.

For the six months ended June 30, 2025, the Company recorded positive foreign currency translation adjustments of $210.5 million that increased shareholders' equity, compared with negative foreign currency translation adjustments of $79.5 million that decreased shareholders' equity for the six months ended June 30, 2024. The foreign currency translation adjustments for the six months ended June 30, 2025 were impacted by the weakening of the U.S. dollar relative to other foreign currencies, including the Euro, the Chinese Renminbi, and the Romanian Leu.

Foreign currency exchange gains and losses, net of hedging activity, resulting from transactions included in the Company's operating results for the three months ended June 30, 2025 totaled $4.4 million of net losses, compared with $0.4 million of net losses during the three months ended June 30, 2024. Foreign currency exchange gains and losses, net of hedging activity, resulting from transactions included in the Company's operating results for the six months ended June 30, 2025 totaled $3.3 million of net losses, compared with $3.6 million of net losses during the six months ended June 30, 2024.

**CEO Transition:**

On September 5, 2024, the Company's Board appointed Tarak B. Mehta President and CEO and appointed Richard G. Kyle Advisor to the CEO. Mr. Mehta succeeded Mr. Kyle, who had served as Timken's President and CEO since 2014. On March 31, 2025, Timken announced that the Company and Mr. Mehta had mutually agreed that Mr. Mehta would depart from the Company, including resigning as a member of the Company's Board, effective immediately. The Company also announced that the Board had appointed Mr. Kyle as the interim President and CEO of the Company, effective immediately. During the three months ended March 31, 2025, the Company recorded severance of $9.3 million, plus related taxes, for Mr. Mehta's settlement arrangement and release of claims for his termination without cause. Approximately two-thirds of this amount is expected to be paid in 2025, with the remaining amounts paid in 2026 and 2027. In addition, the Company recorded stock compensation expense related to a deferred share award issued to Mr. Kyle.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*NON-GAAP MEASURES*

**Supplemental Non-GAAP Measures:**

In addition to results reported in accordance with U.S. GAAP, the Company provides information on non-GAAP financial measures. These non-GAAP financial measures include adjusted net income, adjusted earnings per share, adjusted EBITDA and adjusted EBITDA margins, ratio of net debt to adjusted EBITDA (for the trailing 12 months), net debt, ratio of net debt to capital, free cash flow and return on invested capital. This information is intended to supplement GAAP financial measures and is not intended to replace GAAP financial measures. Net debt and the ratio of net debt to capital is disclosed in the "Liquidity and Capital Resources" section of Management's Discussion and Analysis of Financial Condition and Results of Operations.

**Adjusted Net Income and Adjusted EBITDA:**

Adjusted net income and adjusted earnings per share represent net income attributable to The Timken Company and diluted earnings per share, respectively, adjusted for the amortization of intangible assets related to acquisitions, impairment, restructuring and reorganization charges, acquisition costs, including transaction costs and the amortization of the inventory step-up, property losses and recoveries, actuarial gains and losses associated with the remeasurement of the Company's defined benefit pension and other postretirement benefit plans, gains and losses on the sale of real estate, gains and losses on divestitures, the income tax impact of these adjustments, as well as other income tax discrete items, and other items from time to time that are not part of the Company's core operations. Management believes adjusted net income and adjusted earnings per share are useful to investors as they are representative of the Company's core operations and are used in the management of the business.

Adjusted EBITDA represents earnings before interest, taxes, depreciation and amortization, adjusted for items that are not part of the Company's core operations. These items include impairment, restructuring and reorganization charges, acquisition costs, including transaction costs and the amortization of the inventory step-up, property losses and recoveries, actuarial gains and losses associated with the remeasurement of the Company's defined benefit pension and other postretirement benefit plans, gains and losses on the sale of real estate, gains and losses on divestitures, and other items from time to time that are not part of the Company's core operations. Management believes adjusted EBITDA is useful to investors as it is representative of the Company's core operations and is used in the management of the business, including decisions concerning the allocation of resources and assessment of performance.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

Reconciliation of net income attributable to The Timken Company to adjusted net income, adjusted EBITDA and adjusted EBITDA Margin:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | 2024 | **2025** | 2024 |
| Net Sales | $**1173.4** | $1182.3 | $**2313.7** | $2372.6 |
| Net Income Attributable to The Timken Company | **78.5** | 96.2 | **156.8** | 199.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net Income Attributable to The Timken Company<br>as a Percentage of Sales | **6.7%** | 8.1% | **6.8%** | 8.4% |
| Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition intangible amortization | **19.9** | 19.0 | **38.9** | 39.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment, restructuring and reorganization charges <sup>(1)</sup> | **5.0** | 4.9 | **8.2** | 9.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related charges <sup>(2)</sup> | **—** | 3.0 | **—** | 7.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of certain assets <sup>(3)</sup> | **(0.1)** | (0.2) | **(1.3)** | (0.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;CEO transition expenses <sup>(4)</sup> | **3.2** | 1.1 | **11.8** | 1.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling interest of above adjustments | **1.0** |  | **4.8** | (0.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for income taxes <sup>(7)</sup> | **(8.2)** | (8.8) | **(21.3)** | (15.3) |
| Adjusted Net Income | $**99.3** | $115.2 | $**197.9** | $240.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to noncontrolling interest | **7.2** | 5.8 | **20.3** | 12.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for income taxes (as reported) | **30.7** | 35.9 | **57.6** | 78.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | **29.8** | 34.6 | **56.3** | 66.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income | **(3.0)** | (5.1) | **(5.3)** | (7.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense <sup>(5)</sup> | **56.9** | 54.0 | **111.9** | 108.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Acquisition intangible amortization | **19.9** | 19.0 | **38.9** | 39.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Noncontrolling interest <sup>(6)</sup> | **1.0** |  | **4.8** | (0.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Provision for income taxes <sup>(7)</sup> | **(8.2)** | (8.8) | **(21.3)** | (15.3) |
| Adjusted EBITDA | $**208.2** | $230.2 | $**416.3** | $476.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA Margin (% of net sales) | **17.7%** | 19.5% | **18.0%** | 20.1% |

---

<sup>(1)</sup> Impairment, restructuring and reorganization charges (including items recorded in cost of products sold) relate to: (i) plant closures; (ii) the rationalization of certain plants; (iii) severance related to cost reduction initiatives; and (iv) impairment of assets. The Company re-assesses its operating footprint and cost structure periodically, and makes adjustments as needed that result in restructuring charges. However, management believes these actions are not representative of the Company's core operations.

<sup>(2)</sup> Acquisition-related charges represent deal-related expenses associated with completed transactions and any resulting inventory step-up impact.

<sup>(3)</sup> Represents the net gain resulting from the sale of certain assets.

<sup>(4)</sup> On March 31, 2025, the Company announced that Tarak B. Mehta, President and CEO of the Company would be departing from the Company, effective immediately, and Richard G. Kyle would be serving as interim President and CEO. CEO transition expenses for 2025 primarily relate to the cost of the settlement agreement with Mr. Mehta in connection with his departure, net of the impact for stock awards forfeited, and incremental stock compensation expense related to a deferred share award issued to Mr. Kyle. During 2024, the Company announced that Mr. Kyle, President and CEO of the Company would be retiring from his position as CEO as of February 15, 2025, and that Mr. Mehta would be appointed CEO on September 5, 2024. CEO transition expenses for 2024 relate to the acceleration of certain stock compensation awards for Mr. Kyle and other one-time costs associated with the transition in 2024.

<sup>(5)</sup> Depreciation and amortization shown excludes depreciation recognized in reorganization charges, if any.

<sup>(6)</sup> Represents the noncontrolling interest impact of the adjustments listed above, as well as the reversal of uncertain tax positions related to Timken India Limited.

<sup>(7)</sup> Provision for income taxes includes the net tax impact on pre-tax adjustments (listed above), the impact of discrete tax items recorded during the respective periods as well as other adjustments to reflect the use of one overall effective tax rate on adjusted pre-tax income in interim periods.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

Diluted earnings and adjusted earnings per share in the table below are based on net income attributable to The Timken Company and adjusted net income, respectively, in the table above.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | 2024 | **2025** | 2024 |
| Diluted earnings per share (EPS) | $**1.12** | $1.36 | $**2.23** | $2.82 |
| Adjusted EPS | $**1.42** | $1.63 | $**2.82** | $3.40 |
| Diluted Shares | **70075084** | 70849254 | **70283847** | 70850792 |

---

**Free Cash Flow:**

Free cash flow represents net cash provided by operating activities less capital expenditures. Management believes free cash flow is useful to investors because it is a meaningful indicator of cash generated from operating activities available for the execution of its business strategy.

Reconciliation of net cash provided by operating activities to free cash flow:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | 2024 | **2025** | 2024 |
| Net cash provided by operating activities | $**111.3** | $124.6 | $**169.9** | $173.9 |
| Capital expenditures | **(33.1)** | (37.3) | **(68.3)** | (81.4) |
| Free cash flow | $**78.2** | $87.3 | $**101.6** | $92.5 |

---

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

**Ratio of Net Debt to Adjusted EBITDA:**

The ratio of net debt to adjusted EBITDA for the trailing twelve months represents total debt less cash and cash equivalents divided by adjusted EBITDA for the trailing twelve months. The Company presents net debt to adjusted EBITDA because it believes it is more representative of the Company's financial position as it is reflective of the Company's ability to cover its net debt obligations with results from its core operations. Net income for the trailing twelve months ended June 30, 2025 and December 31, 2024 was $339.8 million and $375.3 million, respectively. Net debt to adjusted EBITDA for the trailing twelve months was 2.3 and 2.0 at June 30, 2025 and December 31, 2024, respectively.

Reconciliation of Net income to Adjusted EBITDA for the trailing twelve months:

---

| | | |
|:---|:---|:---|
| | **Twelve Months Ended** | **Twelve Months Ended** |
| | **June 30,<br>2025** | December 31,<br>2024 |
| Net income | $**339.8** | $375.3 |
| Provision for income taxes | **97.9** | 118.9 |
| Interest expense | **114.6** | 125.1 |
| Interest income | **(12.3)** | (14.9) |
| Depreciation and amortization | **224.6** | 221.8 |
| &nbsp;&nbsp;Consolidated EBITDA | **764.6** | 826.2 |
| &nbsp;&nbsp;Adjustments: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment, restructuring and reorganization charges <sup>(1)</sup> | $**16.6** | $17.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate pension and other postretirement benefit related income <sup>(2)</sup> | **(1.3)** | (1.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related charges <sup>(3)</sup> | **5.3** | 13.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of certain assets <sup>(4)</sup> | **(15.1)** | (14.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;Property losses and related expenses <sup>(5)</sup> | **1.2** | 1.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;CEO transition expenses <sup>(6)</sup> | **14.3** | 3.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tax indemnification and related items | **(1.1)** | (1.1) |
| &nbsp;&nbsp;&nbsp;&nbsp; Total adjustments | **19.9** | 18.6 |
| Adjusted EBITDA | $**784.5** | $844.8 |
| Net Debt | $**1779.0** | $1689.5 |
| Ratio of Net Debt to Adjusted EBITDA | **2.3** | 2.0 |

---

<sup>(1)</sup> Impairment, restructuring and reorganization charges (including items recorded in cost of products sold) relate to: (i) plant closures; (ii) the rationalization of certain plants; (iii) severance related to cost reduction initiatives; and (iv) impairment of assets. The Company re-assesses its operating footprint and cost structure periodically, and makes adjustments as needed that result in restructuring charges. However, management believes these actions are not representative of the Company's core operations.

<sup>(2)</sup> Corporate pension and other postretirement benefit related income represents actuarial gains that resulted from the remeasurement of plan assets and obligations as a result of changes in assumptions or experience. The Company recognizes actuarial gains and losses in connection with the annual remeasurement in the fourth quarter, or if specific events trigger a remeasurement.

<sup>(3)</sup> Acquisition-related charges represent deal-related expenses associated with completed transactions and any resulting inventory step-up impact.

<sup>(4)</sup> Represents the net gain resulting from sale of certain assets. Gain on sale of certain assets for the third quarter of 2024 included $13.8 million gain related to the sale of the Gaffney, South Carolina plant.

<sup>(5)</sup> Represents property loss and related expenses incurred during the periods presented resulting from property loss that occurred during the second quarter of 2024 at one of the Company's plants in Slovakia.

<sup>(6)</sup> On March 31, 2025, the Company announced that Tarak B. Mehta, President and CEO of the Company would be departing from the Company, effective immediately, and Richard G. Kyle would be serving as interim President and CEO. CEO transition expenses for the twelve months ended June 30, 2025, primarily relate to the cost of the settlement agreement with Mr. Mehta in connection with his departure, net of the impact for stock awards forfeited, and incremental stock compensation expense related to a deferred share award issued to Mr. Kyle. During 2024, the Company announced that Mr. Kyle, President and CEO of the Company would be retiring from his position as CEO as of February 15, 2025, and that Mr. Mehta would be appointed CEO on September 5, 2024. CEO transition expenses for 2024 relate to the acceleration of certain stock compensation awards for Mr. Kyle and other one-time costs associated with the transition in 2024.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

*FORWARD-LOOKING STATEMENTS*

Certain statements set forth in this Form 10-Q and in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 that are not historical in nature (including the Company's forecasts, beliefs and expectations) are "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. In particular, Management's Discussion and Analysis contains numerous forward-looking statements. Forward-looking statements generally will be accompanied by words such as "anticipate," "believe," "could," "estimate," "expect," "forecast," "outlook," "intend," "may," "possible," "potential," "predict," "project" or other similar words, phrases or expressions. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this Form 10-Q. The Company cautions readers that actual results may differ materially from those expressed or implied in forward-looking statements made by or on behalf of the Company due to a variety of factors, such as:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• deterioration in world economic conditions, or in economic conditions in any of the geographic regions in which the Company or its customers or suppliers conduct business, including adverse effects from a global economic slowdown or recession, pandemics, epidemics or other public health concerns, terrorism, or hostilities. This includes: political risks associated with the potential instability of governments and legal systems in countries in which the Company or its customers or suppliers conduct business, changes in currency valuations, additional costs, taxes and restrictions related to repatriation of cash in international jurisdictions, strained geopolitical relations between countries in which we have significant operations, and recent world events that have increased macroeconomic risks posed by international trade disputes, tariffs and sanctions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• negative impacts to the Company's business, results of operations, financial position or liquidity, disruption to the Company's supply chains, and negative impacts to operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the effects of fluctuations in customer demand on sales, product mix and prices in the industries in which the Company operates. This includes: the ability of the Company to respond to rapid changes in customer demand, disruptions to the Company's supply chain, the effects of customer or supplier bankruptcies or liquidations, the impact of changes in industrial business cycles, the ability of the Company to effectively adjust the prices for its products in response to changing dynamics, the effects of distributor inventory corrections reflecting de-stocking of the supply chain and whether conditions of fair trade continue in the Company's markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• competitive factors, including changes in market penetration, increasing price competition by existing or new foreign and domestic competitors, the introduction of new products or services by existing and new competitors, competition for skilled labor and new technology, such as artificial intelligence, that may impact the way the Company's products are produced, sold or distributed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in operating costs. This includes: the effect of changes in the Company's manufacturing processes; changes in costs associated with varying levels of operations and manufacturing capacity; availability and cost of raw materials, energy and fuel; changes in tariff rates and other costs associated with tariffs; disruptions to the Company's supply chain and logistical issues associated with port closures or delays or increased costs; changes in the expected costs associated with product warranty claims especially in industry segments with potential high claim values; changes in the global regulatory landscape (including with respect to climate change or other environmental regulations); changes resulting from inventory management and cost reduction initiatives; the effects of unplanned plant shutdowns; the effects of government-imposed restrictions, commercial requirements and Company goals associated with climate change and emissions or other sustainability initiatives; and changes in the cost of labor and benefits;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the success of the Company's operating plans, announced programs, initiatives and capital investments; the ability to integrate acquired companies and to address material issues both identified and not uncovered during the Company's due diligence review; and the ability of acquired companies to achieve satisfactory operating results, including results being accretive to earnings, realization of synergies and expected cash flow generation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Company's ability to maintain appropriate relations with unions or works councils that represent Company employees in certain locations in order to avoid disruptions of business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the continued attraction, retention and development of management, other key employees, and other skilled personnel, the successful development and execution of succession plans and management of other human capital matters;

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• unanticipated litigation, claims, investigations, remediation or assessments. This includes: claims, investigations or problems related to intellectual property, product liability or warranty, foreign export, sanctions and trade laws, government procurement regulations, competition and anti-bribery laws, climate change, PTFE, PFAS, other environmental or health and safety issues, data privacy, cybersecurity and taxes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the rapidly evolving global regulatory landscape and the corresponding heightened operational complexity and compliance risks;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in worldwide financial and capital markets, including fluctuations in interest rates, impacting the availability of financing on satisfactory terms as a result of financial stress affecting the banking system or otherwise, which affect the Company's cost of funds and/or ability to raise capital, as well as customer demand and the ability of customers to obtain financing to purchase the Company's products or equipment that contain the Company's products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Company's ability to satisfy its obligations and comply with covenants under its debt agreements, maintain favorable credit ratings and its ability to renew or refinance borrowings on favorable terms;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact on the Company's pension obligations and assets due to changes in interest rates, investment performance and other tactics designed to reduce risk; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• those items identified under Item 1A. "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 or this Form 10-Q.

Additional risks relating to the Company's business, the industries in which the Company operates, or the Company's common shares may be described from time to time in the Company's filings with the U.S. Securities and Exchange Commission ("SEC"). All of these risk factors are difficult to predict, are subject to material uncertainties that may affect actual results and may be beyond the Company's control.

Readers are cautioned that it is not possible to predict or identify all of the risks, uncertainties and other factors that may affect future results and that the above list should not be considered to be a complete list. Except as required by the federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

Refer to information appearing under the caption "Management's Discussion and Analysis of Financial Condition and Results of Operations" of this Form 10-Q. Furthermore, a discussion of market risk exposures is included in Part II, Item 7A. Quantitative and Qualitative Disclosure about Market Risk, of the Company's Annual Report on Form 10-K for the year ended December 31, 2024. There have been no material changes in reported market risk since the inclusion of this discussion in the Company's Annual Report on Form 10-K referenced above.

**ITEM 4. CONTROLS AND PROCEDURES**

&nbsp;&nbsp;&nbsp;&nbsp;(a)Disclosure Controls and Procedures

As of the end of the period covered by this report, the Company carried out an evaluation, under the supervision and with the participation of the Company's management, including the Company's principal executive officer and principal financial officer, of the effectiveness of the design and operation of the Company's disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)). Based upon that evaluation, the principal executive officer and principal financial officer concluded that the Company's disclosure controls and procedures were effective as of the end of the period covered by this report.

&nbsp;&nbsp;&nbsp;&nbsp;(b)Changes in Internal Control Over Financial Reporting

During the Company's fiscal quarter ended June 30, 2025, there have been no changes in the Company's internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

**PART II. OTHER INFORMATION**

Item 1. Legal Proceedings

The Company is involved in various claims and legal actions arising in the ordinary course of business. SEC regulations require us to disclose certain information about legal proceedings when a governmental authority is a party to the proceedings if we reasonably believe that such proceedings may result in monetary sanctions above a stated threshold. Pursuant to such regulations, the Company uses a threshold of $1 million or more for purposes of determining whether disclosure of any such proceedings is required. We believe matters under this threshold are not material to the Company. In the opinion of management, the ultimate disposition of open proceedings as of June 30, 2025 will not have a material adverse effect on the Company's consolidated financial position or annual results of operations.

Item 1A. Risk Factors

The Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, included a detailed discussion of our risk factors. There have been no material changes to the risk factors included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024. Investors should not interpret the disclosure of any risk factor to imply that the risk has not already materialized.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

**Issuer Purchases of Common Shares**

The following table provides information about purchases by the Company of its common shares during the quarter ended June 30, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| Period | Total number<br>of shares<br>purchased <sup>(1)</sup> | Average<br>price paid<br>per share <sup>(2)</sup> | Total number<br>of shares<br>purchased as<br>part of publicly<br>announced<br>plans or<br>programs | Maximum<br>number of<br>shares that<br>may yet<br>be purchased<br>under the plans<br>or programs <sup>(3)</sup> |
| 4/1/2025 - 4/30/2025 | **211442** | $**63.14** | **208000** | **1634929** |
| 5/1/2025 - 5/31/2025 | **135613** | **68.63** | **135418** | **1499511** |
| 6/1/2025 - 6/30/2025 | **227** | **72.52** | **—** | **1499511** |
| **Total** | **347282** | $**65.29** | **343418** | **—** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Of the shares purchased in April, May, and June, 3,442, 195, and 227, respectively, represent common shares of the Company that were owned and tendered by employees to exercise stock options and to satisfy withholding obligations in connection with the exercise of stock options or vesting of restricted shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)For shares tendered in connection with the vesting of restricted shares, the average price paid per share is an average calculated using the daily high and low of the Company's common shares as quoted on the New York Stock Exchange at the time of vesting. For shares tendered in connection with the exercise of stock options, the price paid is the real-time trading stock price at the time the options are exercised.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)On February 12, 2021, the Company's Board of Directors approved a new share purchase plan, effective March 1, 2021, pursuant to which the Company may purchase up to ten million of its common shares, in the aggregate. This share purchase plan expires on February 28, 2026. Under this plan, the Company may purchase shares from time to time in open market purchases or privately negotiated transactions, and it may make all or part of the purchases pursuant to accelerated share repurchases or Rule 10b5-1 plans.

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

Item 5. Other Information

During the fiscal quarter ended June 30, 2025, no director or officer (as defined in Exchange Act Rule 16a-1(f)) of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" (as each term is defined in Regulation 408(a) of Regulation S-K).

Item 6. Exhibits

---

| | |
|:---|:---|
| <u>[31.1](tkr6302025exhibit311.htm)</u> | Certification of Richard G. Kyle, President and Chief Executive Officer (principal executive officer) of The Timken Company, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| <u>[31.2](tkr6302025exhibit312.htm)</u> | Certification of Philip D. Fracassa, Executive Vice President and Chief Financial Officer (principal financial officer and principal accounting officer) of The Timken Company, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| <u>[32](tkr6302025exhibit32.htm)</u> | Certifications of Richard G. Kyle, President and Chief Executive Officer (principal executive officer) and Philip D. Fracassa, Executive Vice President and Chief Financial Officer (principal financial officer and principal accounting officer) of The Timken Company, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| <u>[101](#i38983723d3ff4cd89864b8cd2aa3c059_13)</u> | Financial statements from the quarterly report on Form 10-Q of The Timken Company for the quarter ended June 30, 2025 filed on July 30, 2025, formatted in Inline XBRL: (i) the Consolidated Statements of Income, (ii) the Consolidated Statements of Comprehensive Income, (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Cash Flows and (v) the Notes to the Consolidated Financial Statements. |
| <u>[104](#i38983723d3ff4cd89864b8cd2aa3c059_1)</u> | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |

---

------

<u>[**Table of Contents**](#i38983723d3ff4cd89864b8cd2aa3c059_7)</u>

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| | THE TIMKEN COMPANY |
| Date: July 30, 2025 | By: /s/ Richard G. Kyle |
|  | Richard G. Kyle<br>President and Chief Executive Officer<br>(Principal Executive Officer) |
| Date: July 30, 2025 | By: /s/ Philip D. Fracassa |
|  | Philip D. Fracassa<br>Executive Vice President and Chief Financial Officer<br>(Principal Financial Officer and Principal Accounting Officer) |

---

## Exhibit 31.1

Exhibit 31.1

Principal Executive Officer's Certifications

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Richard G. Kyle, certify that:

1. &nbsp;&nbsp;&nbsp;&nbsp;I have reviewed this quarterly report on Form 10-Q of The Timken Company;

2.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting: and

5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: July 30, 2025

---

| |
|:---|
| By: /s/ Richard G. Kyle |
| Richard G. Kyle<br>President and Chief Executive Officer<br>(Principal Executive Officer) |

---

## Exhibit 31.2

Exhibit 31.2

Principal Financial Officer's Certifications

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Philip D. Fracassa, certify that:

1. I have reviewed this quarterly report on Form 10-Q of The Timken Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting: and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: July 30, 2025

---

| |
|:---|
| By: /s/ Philip D. Fracassa |
| Philip D. Fracassa<br>Executive Vice President and Chief Financial Officer<br>(Principal Financial Officer and Principal Accounting Officer) |

---

## Ex-32

Exhibit 32

Certification Pursuant to

18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report of The Timken Company (the "Company") on Form 10-Q for the period ended June 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. 1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act of 2002, that, to such officer's knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.

Date: July 30, 2025

---

| |
|:---|
| By: /s/ Richard G. Kyle |
| Richard G. Kyle<br>President and Chief Executive Officer<br>(Principal Executive Officer) |

---

---

| |
|:---|
| By: /s/ Philip D. Fracassa |
| Philip D. Fracassa<br>Executive Vice President and Chief Financial Officer<br>(Principal Financial Officer and Principal Accounting Officer) |

---

The foregoing certification is being furnished solely pursuant to 18 U.S.C. 1350 and is not being filed as part of the Report or as a separate disclosure document.

<br>